Scott B Baron, MD
Interventional Cardiology · Carmichael
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 47 years
- Rutgers New Jersey Medical School, 1979
Offices
1 location · Dignity Health Medical Foundation · 1,211 clinicians in this group
Looking this up.
Hospitals listed: Mercy San Juan Medical Center · Sutter Medical Center, Sacramento · Sutter Roseville Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Baron’s office at (916) 536-3560 to ask if they take your plan before you enroll.
California Medical Board record
Licence G42165 · Current
Licensed to practise in California · since 1980 · expires 2028-06-30 · Umdnj New Jersey Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Cardiovascular Disease
- American Board of Internal Medicine - Internal Medicine
- American Board of Internal Medicine - Interventional Cardiology
Hospitals they work in
3 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Mercy San Juan Medical CenterCarmichael, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 69% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.108, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.144, Oct 2024 – Sep 2025
- Sutter Medical Center, SacramentoSacramento, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 3 of 5 · 79% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 13.9 (12 to 15.9) · 992 cases, Jan 2024 – Dec 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.066, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.335, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.215, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.46, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.253, Oct 2024 – Sep 2025
- Sutter Roseville Medical CenterRoseville, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 79% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Pressure ulcer rate: 0.08 (0 to 0.56) · 12,400 cases, Jul 2022 – Jun 2024Better than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.069, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.262, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.128, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.357, Oct 2024 – Sep 2025
See every measure and the patient survey for Mercy San Juan Medical Center
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 8 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.108 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.144 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.78 (0 to 1.72) · 1,413 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.77 (0.47 to 1.07) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 195.56 (150.94 to 240.19) · 122 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.9 · 45 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.6 · 193 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 14.6 · 190 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.9 · 445 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.7 · 444 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.2 · 518 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 3,727 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.19 (0 to 0.39) · 8,263 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.05 to 0.42) · 8,488 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.3 (0.42 to 4.18) · 1,992 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0 to 2.95) · 566 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.08 (0.71 to 3.44) · 1,929 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.41 (0 to 13) · 533 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.3 (0.68 to 7.92) · 557 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.6 (0.14 to 3.06) · 338 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.53 (0 to 1.11) · 7,155 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.3 · 48 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.567 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.1 · 283 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.2 · 852 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.4 · 183 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -14.6 · 522 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -12.4 · 458 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.9 · 708 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.1 to 7.5) · 102 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10 (7 to 14) · 102 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 6.1 · 57 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.3 · 51 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.2 · 379 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.8 (9.5 to 17.2) · 384 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.1 (0.8 to 1.4) · 291 cases | No different | Jan 2024 – Dec 2024 |
What patients said (611 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 64% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 86% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 68% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 69% |
| Staff "always" explained possible side effects | 50% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for Sutter Medical Center, Sacramento
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 13.9 (12 to 15.9) · 992 cases | Worse | Jan 2024 – Dec 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.066 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.335 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.215 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.46 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.253 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.12 (0.29 to 1.94) · 2,408 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.99 (0.78 to 1.2) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 166.68 (126.66 to 206.71) · 180 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 292 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.2 · 359 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.8 · 543 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.9 · 425 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 441 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3 · 5,216 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.11 (0 to 0.29) · 9,948 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.1 to 0.45) · 10,968 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.04 (1.53 to 4.56) · 3,983 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0.2 to 2.46) · 2,033 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.78 (1.69 to 3.87) · 3,594 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.79 (6.29 to 13.29) · 2,100 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.62 (4.04 to 9.2) · 2,018 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.63 (0.29 to 2.98) · 867 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0.07 to 1.01) · 8,613 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.3 · 294 cases | None | Apr 2023 – Mar 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.5 · 598 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.9 · 924 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 8.5 · 488 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -18.3 · 638 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.4 · 443 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.7 · 600 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.9 to 6.1) · 992 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.1 · 298 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9 · 249 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 250 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 11.3 (8.7 to 14.6) · 1,326 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 934 cases | No different | Jan 2024 – Dec 2024 |
What patients said (700 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 2 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 86% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 79% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Sutter Roseville Medical Center
Behind the star rating — Deaths: 2 better, 5 the same, 0 worse of 7 measures. Safety: 5 better, 1 the same, 1 worse of 7 measures. Readmissions: 2 better, 7 the same, 1 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Pressure ulcer rateComplications and deaths | 0.08 (0 to 0.56) · 12,400 cases | Better | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.069 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.262 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.128 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.357 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.33 (0.49 to 2.17) · 2,916 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.9 (0.63 to 1.17) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 147.2 (107.33 to 187.07) · 191 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.9 · 250 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.7 · 484 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.4 · 839 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.3 · 1,027 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10 · 656 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,822 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.08 to 0.42) · 14,300 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.06 to 0.41) · 14,490 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 4.43 (2.77 to 6.08) · 3,117 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.38 (0 to 2.95) · 938 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.06 (0.76 to 3.36) · 2,944 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 9.03 (2.8 to 15.25) · 840 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 6.43 (3.11 to 9.75) · 899 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.34 to 3.11) · 819 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.4 · 35 cases | None | Apr 2023 – Mar 2025 |
| SSI - Colon SurgeryInfections | 0.41 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.9 · 527 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.6 · 1,094 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -16.6 · 443 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -11 · 961 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -8 · 1,064 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 1,293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.5 (3.5 to 8.7) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (6.9 to 14.9) · 35 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 36 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 310 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.2 (9.8 to 17.9) · 116 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 1,600 cases | No different | Jan 2024 – Dec 2024 |
What patients said (537 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 74% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 77% |
| Staff "always" explained new medications | 77% |
| Nurses "always" explained things so they could understand | 78% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 52% |
| "YES", patients would definitely recommend the hospital | 79% |
| Staff "always" explained possible side effects | 47% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$302,783
Medicare paid this office $302,783 for 782 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 409 | $99,799 | $149 |
| Return visit (30+ min) | 402 | $53,375 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 226 | $40,986 | $168 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 660 | $14,144 | $12 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 45 | $12,973 | $101 |
See all 22 services
| Long return visit (40+ min) | 409 | $99,799 | $149 |
| Return visit (30+ min) | 402 | $53,375 | $96 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 226 | $40,986 | $168 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 660 | $14,144 | $12 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 45 | $12,973 | $101 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 51 | $9,884 | $190 |
| New patient visit (60+ min) | 48 | $8,545 | $178 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 13 | $7,306 | $430 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 39 | $5,103 | $111 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 27 | $3,842 | $67 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $3,472 | $267 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 16 | $2,972 | $186 |
| New patient visit (45+ min) | 21 | $2,661 | $127 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 41 | $2,649 | $59 |
| Programming of dual lead pacemaker system | 33 | $2,513 | $66 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 46 | $2,495 | $24 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 11 | $1,625 | $148 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 65 | $1,443 | $22 |
| Short return visit (20+ min) | 14 | $919 | $66 |
| Heart rhythm recording of continous external ekg over 8-15 days | 65 | $741 | $11 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 12 | $660 | $23 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 39 | $468 | $10 |
Procedures Medicare counted
| Coronary angioplasty and stenting | 32 | More than 67% of doctors who do this |
| Leg revascularization (restoring blood flow) | 1-10 | None |
| Pacemaker insertion or repair | 1-10 | None |
Who their Medicare patients are
782 Original Medicare patients in 2024. Average age 78 · Under 65 3% · 85 and older 24% · Women 51% · Also on Medicaid 14% · Health risk score 1.57. At or below the middle of the specialty; the typical interventional cardiology clinician is at 1.7.
Conditions among them: High blood pressure 75% · Coronary heart disease 53% · Heart failure 43% · Atrial fibrillation 38% · Diabetes 35% · Chronic kidney disease 34% · COPD 20% · Cancer 18% · Depression 18% · Stroke 14% · Dementia 7%.
The office billed $2,156,941, Medicare allowed $406,550 and paid $302,783; for 3,733 services of 87 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 782 | 3,733 | 78 | 1.57 | $2,156,941 | $302,783 |
| 2023 | 786 | 3,826 | 79 | 1.52 | $2,188,103 | $297,160 |
| 2022 | 968 | 5,195 | 79 | 1.51 | $1,056,648 | $355,071 |
| 2021 | 1,012 | 6,279 | 78 | 1.51 | $1,268,612 | $473,602 |
| 2020 | 1,026 | 6,130 | 79 | 1.55 | $1,263,534 | $464,507 |
| 2019 | 1,241 | 6,560 | 78 | 1.62 | $1,352,051 | $467,579 |
| 2018 | 1,082 | 4,749 | 78 | 1.61 | $991,979 | $324,276 |
| 2017 | 1,334 | 7,023 | 77 | 1.69 | $1,529,955 | $594,727 |
| 2016 | 1,449 | 7,316 | 77 | 1.69 | $1,594,751 | $524,035 |
| 2015 | 1,472 | 7,457 | 77 | 1.66 | $1,671,429 | $575,342 |
| 2014 | 1,439 | 7,815 | 76 | 1.47 | $1,646,550 | $560,288 |
| 2013 | 1,549 | 8,541 | 76 | 1.55 | $1,771,828 | $593,878 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 27 services
| Return visit (30+ min) | 568 | $111,677 | $104 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 278 | $47,057 | $162 |
| Long return visit (40+ min) | 95 | $18,508 | $152 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 65 | $12,763 | $193 |
| Short return visit (20+ min) | 149 | $12,259 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 608 | $11,826 | $12 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 68 | $11,188 | $64 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 18 | $9,082 | $413 |
| New patient visit (45+ min) | 56 | $6,945 | $124 |
| New patient visit (60+ min) | 38 | $6,100 | $161 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 15 | $4,280 | $285 |
| Programming of dual lead pacemaker system | 37 | $3,027 | $62 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 47 | $2,921 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,485 | $108 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 16 | $2,440 | $152 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 29 | $2,330 | $69 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 12 | $2,278 | $99 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 42 | $1,986 | $23 |
| Heart rhythm review and interpretation of continous external ekg over 8-15 days | 79 | $1,784 | $21 |
| Insertion of tube in left heart chambers for diagnosis with review by radiologist | 12 | $1,775 | $137 |
| New patient visit (30+ min) | 19 | $1,341 | $71 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $1,025 | $39 |
| Programming of multiple lead pacemaker system | 12 | $970 | $69 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 11 | $824 | $75 |
| Heart rhythm recording of continous external ekg over 8-15 days | 62 | $708 | $11 |
| Evaluation of implantable heart and blood vessel monitoring system, remote up to 30 days | 14 | $610 | $19 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 44 | $495 | $10 |
2022: 32 services
| Return visit (30+ min) | 602 | $98,448 | $94 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 291 | $47,580 | $155 |
| Short return visit (20+ min) | 333 | $27,241 | $62 |
| Long return visit (40+ min) | 111 | $18,132 | $135 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 811 | $17,449 | $11 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 74 | $17,012 | $84 |
| Ultrasound of both sides of head and neck blood flow | 70 | $11,116 | $157 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 25 | $9,828 | $393 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 50 | $8,773 | $160 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 16 | $8,057 | $424 |
| Injection, regadenoson, 0.1 mg | 39 | $7,257 | None |
| New patient visit (45+ min) | 52 | $6,321 | $122 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 31 | $5,836 | $188 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 26 | $4,945 | $190 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 73 | $4,401 | $58 |
| Telephone medical discussion with physician, 11-20 minutes | 56 | $4,258 | $69 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 50 | $3,643 | $40 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 12 | $3,329 | $277 |
| New patient visit (60+ min) | 21 | $3,298 | $157 |
| Return visit (30+ min) | 36 | $3,028 | $82 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 52 | $2,800 | $53 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 57 | $2,796 | $23 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 64 | $2,472 | $18 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring and review and report by health care professional | 13 | $2,232 | $159 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,769 | $59 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 24 | $1,426 | $59 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,090 | $84 |
| Hospital discharge day management, 30 minutes or less | 12 | $720 | $60 |
| Programming of dual lead pacemaker system | 14 | $688 | $46 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 56 | $608 | $10 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 11 | $236 | $21 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 12 | $29 | $2 |
2021: 33 services
| Return visit (30+ min) | 707 | $137,809 | $97 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 352 | $62,132 | $166 |
| Short return visit (20+ min) | 375 | $38,459 | $71 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 42 | $27,382 | $622 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 858 | $21,271 | $11 |
| Ultrasound of both sides of head and neck blood flow | 103 | $16,810 | $160 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 87 | $15,627 | $91 |
| Long return visit (40+ min) | 91 | $15,130 | $147 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 25 | $13,340 | $392 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 62 | $13,192 | $85 |
| Injection, regadenoson, 0.1 mg | 67 | $12,229 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 53 | $8,965 | $166 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 21 | $8,609 | $410 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 38 | $6,842 | $180 |
| New patient visit (45+ min) | 47 | $6,172 | $131 |
| New patient visit (60+ min) | 33 | $5,978 | $181 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 21 | $5,650 | $269 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 24 | $4,841 | $202 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 87 | $4,709 | $54 |
| Return visit (30+ min) | 50 | $4,666 | $83 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 52 | $3,438 | $59 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 50 | $3,181 | $61 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 61 | $2,874 | $20 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 53 | $2,864 | $23 |
| Ultrasound of heart with probe in esophagus, with report | 25 | $2,370 | $88 |
| Review by radiologist of arm or leg artery image | 29 | $2,072 | $69 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 20 | $1,549 | $60 |
| External shock to heart to regulate heart beat | 12 | $1,191 | $92 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 43 | $973 | $22 |
| Hospital discharge day management, 30 minutes or less | 15 | $902 | $60 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 61 | $674 | $10 |
| Programming of dual lead pacemaker system | 20 | $645 | $29 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 25 | $69 | $3 |
2020: 34 services
| Return visit (30+ min) | 727 | $118,724 | $83 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 327 | $60,185 | $166 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 103 | $42,632 | $414 |
| Short return visit (20+ min) | 370 | $26,979 | $55 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 845 | $22,447 | $13 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 103 | $19,973 | $98 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 79 | $19,512 | $88 |
| Electrocardiogram (ecg) up to 30 days continuous with transmission of patient triggered events with review and report by health care professional | 30 | $19,222 | $620 |
| Ultrasound of both sides of head and neck blood flow | 93 | $15,672 | $165 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 82 | $14,828 | $165 |
| Injection, regadenoson, 0.1 mg | 77 | $14,091 | None |
| Long return visit (40+ min) | 72 | $9,306 | $118 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 16 | $8,583 | $452 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 41 | $7,712 | $184 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 103 | $5,500 | $53 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 28 | $5,146 | $184 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 18 | $5,024 | $279 |
| New patient visit (45+ min) | 34 | $3,951 | $116 |
| New patient visit (60+ min) | 18 | $2,850 | $158 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 70 | $2,739 | $21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 61 | $2,678 | $25 |
| Return visit (30+ min) | 39 | $2,668 | $67 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 33 | $2,141 | $63 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 30 | $2,075 | $69 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 17 | $1,458 | $61 |
| External shock to heart to regulate heart beat | 12 | $1,311 | $94 |
| Programming of dual lead pacemaker system | 39 | $1,288 | $29 |
| Hospital discharge day management, 30 minutes or less | 19 | $1,173 | $62 |
| Review by radiologist of arm or leg artery image | 12 | $933 | $72 |
| Electrocardiogram (ecg) up to 30 days continuous with review and report by health care professional | 30 | $700 | $23 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 11 | $622 | $31 |
| Ultrasonic guidance for blood vessel access | 42 | $513 | $12 |
| Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes | 47 | $511 | $10 |
| Short return visit | 11 | $291 | $26 |
2019: 30 services
| Return visit (30+ min) | 824 | $138,587 | $82 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 312 | $55,444 | $166 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 70 | $31,004 | $419 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 947 | $26,967 | $13 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 99 | $24,283 | $86 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 89 | $17,370 | $94 |
| Ultrasound of both sides of head and neck blood flow | 102 | $17,036 | $165 |
| Long return visit (40+ min) | 111 | $13,643 | $111 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 24 | $13,408 | $406 |
| Short return visit (20+ min) | 223 | $13,136 | $55 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 68 | $13,062 | $189 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 167 | $10,895 | $61 |
| Injection, regadenoson, 0.1 mg | 54 | $10,133 | None |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 45 | $7,870 | $164 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 27 | $7,397 | $264 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 58 | $7,298 | $111 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 37 | $7,059 | $191 |
| New patient visit (45+ min) | 59 | $7,007 | $119 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 89 | $4,994 | $54 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 61 | $4,300 | $67 |
| New patient visit (60+ min) | 15 | $2,436 | $162 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 50 | $2,053 | $25 |
| External shock to heart to regulate heart beat | 19 | $1,843 | $92 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 58 | $1,791 | $22 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 23 | $1,742 | $60 |
| Ultrasound of heart with probe in esophagus, with report | 17 | $1,559 | $92 |
| Programming of dual lead pacemaker system | 34 | $1,271 | $28 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 11 | $1,008 | $37 |
| Ultrasonic guidance for blood vessel access | 54 | $659 | $12 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 17 | $46 | $3 |
2018: 31 services
| Return visit (30+ min) | 710 | $79,425 | $75 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 314 | $48,411 | $145 |
| Long return visit (40+ min) | 269 | $41,992 | $112 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 826 | $18,299 | $12 |
| Ultrasound of both sides of head and neck blood flow | 93 | $15,100 | $161 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 60 | $14,537 | $82 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 66 | $12,288 | $92 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 27 | $9,867 | $365 |
| Injection, regadenoson, 0.1 mg | 44 | $7,980 | None |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 117 | $6,976 | $58 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 15 | $6,865 | $404 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 34 | $6,073 | $179 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 44 | $4,501 | $102 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 27 | $4,489 | $160 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 15 | $3,750 | $250 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 64 | $3,340 | $51 |
| New patient visit (60+ min) | 16 | $2,488 | $156 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 34 | $2,365 | $66 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 13 | $2,241 | $160 |
| Short return visit (20+ min) | 38 | $1,920 | $48 |
| New patient visit (45+ min) | 17 | $1,836 | $108 |
| Programming of dual lead pacemaker system | 41 | $1,621 | $26 |
| Ultrasound of heart with probe in esophagus, with report | 14 | $1,223 | $87 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 16 | $1,150 | $57 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 41 | $995 | $20 |
| Programming of dual lead implantable defibrillator system | 15 | $928 | $44 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 34 | $837 | $20 |
| Programming of multiple lead implantable defibrillator system | 12 | $647 | $43 |
| Programming of single lead pacemaker system | 11 | $271 | $18 |
| Ultrasonic guidance for blood vessel access | 13 | $148 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 14 | $36 | $3 |
2017: 34 services
| Return visit (30+ min) | 915 | $159,262 | $89 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 152 | $71,287 | $466 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 274 | $61,676 | $210 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 112 | $35,799 | $97 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 152 | $33,260 | $109 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 998 | $28,931 | $15 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 27 | $17,064 | $474 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 261 | $16,037 | $59 |
| Ultrasound of both sides of head and neck blood flow | 76 | $14,514 | $191 |
| Long return visit (40+ min) | 89 | $13,636 | $130 |
| Injection, regadenoson, 0.1 mg | 76 | $13,099 | None |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 87 | $11,566 | $123 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 46 | $11,113 | $242 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 49 | $9,810 | $196 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 149 | $9,650 | $64 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 11 | $6,562 | $597 |
| New patient visit (45+ min) | 42 | $5,874 | $140 |
| New patient visit (60+ min) | 33 | $5,767 | $175 |
| Short return visit (20+ min) | 89 | $5,501 | $59 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 65 | $5,057 | $75 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $3,965 | $305 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $3,384 | $188 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 49 | $3,046 | $25 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 11 | $2,925 | $266 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 37 | $2,764 | $30 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 30 | $2,708 | $68 |
| Programming of dual lead pacemaker system | 50 | $2,517 | $31 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 13 | $1,910 | $62 |
| External shock to heart to regulate heart beat | 17 | $1,782 | $94 |
| Ultrasound of heart with probe in esophagus, with report | 15 | $1,554 | $104 |
| Programming of dual lead implantable defibrillator system | 14 | $1,101 | $52 |
| Hospital discharge day management, 30 minutes or less | 14 | $1,026 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 12 | $103 | $8 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 13 | $39 | $3 |
2016: 36 services
| Return visit (30+ min) | 831 | $126,689 | $78 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 293 | $58,192 | $182 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 103 | $43,311 | $412 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 139 | $34,968 | $84 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 991 | $25,454 | $13 |
| Short return visit (20+ min) | 382 | $21,784 | $51 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 103 | $19,846 | $95 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 377 | $19,630 | $50 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 78 | $16,331 | $204 |
| Injection, regadenoson, 0.1 mg | 88 | $15,209 | None |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 27 | $14,240 | $432 |
| Ultrasound of both sides of head and neck blood flow | 87 | $13,164 | $148 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 58 | $11,113 | $185 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 17 | $9,412 | $495 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 58 | $9,263 | $149 |
| Long return visit (40+ min) | 61 | $7,335 | $111 |
| New patient visit (45+ min) | 60 | $6,779 | $113 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 56 | $6,474 | $110 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 100 | $5,641 | $55 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 70 | $5,528 | $69 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 49 | $4,911 | $58 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 15 | $4,417 | $294 |
| New patient visit (60+ min) | 24 | $4,028 | $168 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 15 | $2,761 | $184 |
| External shock to heart to regulate heart beat | 20 | $2,411 | $100 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 42 | $2,393 | $21 |
| Programming of dual lead pacemaker system | 56 | $2,389 | $27 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 37 | $2,366 | $27 |
| Ultrasound of heart with probe in esophagus, with report | 20 | $1,988 | $99 |
| Long return visit (40+ min) | 16 | $1,981 | $90 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 18 | $1,926 | $52 |
| Hospital discharge day management, 30 minutes or less | 17 | $1,063 | $59 |
| Hospital observation care on day of discharge | 17 | $948 | $56 |
| Injection for imaging of aorta above heart valve with review by radiologist | 13 | $547 | $42 |
| Electrocardiogram (ecg) up to 30 days continuous with symptom monitoring | 11 | $93 | $8 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 19 | $50 | $3 |
2015: 36 services
| Return visit (30+ min) | 994 | $164,942 | $80 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 310 | $61,870 | $185 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 121 | $50,018 | $391 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 127 | $34,069 | $84 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 121 | $33,430 | $132 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,032 | $26,033 | $13 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 116 | $20,132 | $160 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 29 | $17,778 | $468 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 344 | $17,435 | $49 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 79 | $16,529 | $209 |
| Ultrasound of both sides of head and neck blood flow | 85 | $13,671 | $159 |
| Injection, regadenoson, 0.1 mg | 79 | $12,984 | None |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 21 | $11,439 | $440 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 53 | $9,451 | $172 |
| New patient visit (45+ min) | 67 | $8,521 | $127 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 121 | $7,093 | $55 |
| New patient visit (60+ min) | 35 | $5,855 | $167 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 66 | $5,437 | $70 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 15 | $4,269 | $285 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 45 | $4,060 | $59 |
| Programming of dual lead pacemaker system | 65 | $3,411 | $30 |
| Short return visit (20+ min) | 55 | $2,999 | $52 |
| Long return visit (40+ min) | 27 | $2,905 | $100 |
| Insertion of tube into chest or arm artery, initial third order branch | 13 | $2,641 | $203 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 44 | $2,258 | $21 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 33 | $2,094 | $27 |
| Ultrasound of heart with probe in esophagus, with report | 21 | $2,088 | $99 |
| External shock to heart to regulate heart beat | 15 | $1,914 | $101 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 15 | $1,576 | $51 |
| Hospital discharge day management, 30 minutes or less | 23 | $1,370 | $60 |
| Hospital observation care on day of discharge | 11 | $653 | $59 |
| Injection for imaging of aorta above heart valve with review by radiologist | 11 | $464 | $42 |
| Ultrasound of heart blood flow, valves and chambers | 20 | $302 | $15 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 14 | $111 | $7 |
| Injection, aminophyllin, up to 250 mg | 16 | $73 | None |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 20 | $53 | $3 |
2014: 38 services
| Return visit (30+ min) | 1,029 | $163,203 | $78 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 319 | $62,383 | $188 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 136 | $49,287 | $340 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 135 | $37,751 | $131 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 142 | $35,217 | $84 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,080 | $26,283 | $12 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 124 | $22,447 | $163 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 82 | $19,328 | $230 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 296 | $14,437 | $47 |
| Ultrasound of both sides of head and neck blood flow | 85 | $13,051 | $147 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 23 | $12,825 | $401 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 20 | $12,374 | $516 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 46 | $8,019 | $171 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 135 | $7,730 | $54 |
| Injection, regadenoson, 0.1 mg | 42 | $6,807 | None |
| New patient visit (60+ min) | 44 | $6,038 | $137 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 68 | $5,058 | $68 |
| Short return visit (20+ min) | 106 | $4,931 | $43 |
| New patient visit (45+ min) | 39 | $4,625 | $119 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 13 | $3,775 | $290 |
| Long return visit (40+ min) | 37 | $3,487 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 35 | $3,140 | $58 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 44 | $2,472 | $26 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 49 | $2,427 | $21 |
| External shock to heart to regulate heart beat | 16 | $2,192 | $100 |
| Ultrasound of heart with probe in esophagus, with report | 25 | $2,077 | $80 |
| Hospital discharge day management, 30 minutes or less | 27 | $1,646 | $59 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system, remote up to 90 days | 12 | $1,467 | $51 |
| Programming of dual lead pacemaker system | 27 | $1,039 | $34 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 23 | $767 | $24 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 55 | $613 | $7 |
| Injection for imaging of aorta above heart valve with review by radiologist | 14 | $555 | $40 |
| Ultrasound of heart blood flow, valves and chambers | 25 | $377 | $14 |
| Ultrasound of heart, follow-up | 12 | $377 | $21 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 13 | $170 | $11 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 35 | $118 | $3 |
| Injection, dipyridamole, per 10 mg | 39 | $115 | None |
| Injection, aminophyllin, up to 250 mg | 44 | $91 | None |
2013: 39 services
| Return visit (30+ min) | 912 | $139,331 | $79 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 173 | $62,732 | $361 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 292 | $46,310 | $151 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 173 | $41,515 | $119 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 149 | $33,963 | $81 |
| Short return visit (20+ min) | 514 | $32,612 | $49 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 1,144 | $30,860 | $14 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 128 | $21,746 | $159 |
| Insertion of stents with balloon dilation of coronary artery or branch, single artery or branch | 35 | $18,479 | $411 |
| Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | 86 | $16,174 | $182 |
| Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | 309 | $14,083 | $45 |
| Ultrasound of both sides of head and neck blood flow | 94 | $13,498 | $141 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 172 | $9,882 | $57 |
| Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist | 52 | $9,661 | $179 |
| New patient visit (45+ min) | 86 | $9,640 | $112 |
| Injection, regadenoson, 0.1 mg | 57 | $9,618 | None |
| New patient visit (60+ min) | 56 | $8,903 | $159 |
| Removal of plaque and blood clot, insertion of stent and/or balloon dilation of single vessel | 16 | $8,655 | $456 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 72 | $7,069 | $57 |
| Insertion of tube in right and left heart chambers and coronary artery for diagnosis with review by radiologist | 25 | $6,387 | $255 |
| Electrocardiogram (ecg) 2-day continuous with review and report by health care professional | 64 | $4,643 | $67 |
| Long return visit (40+ min) | 37 | $4,182 | $105 |
| Insertion of tube in left lower heart chamber, coronary artery and bypass graft for diagnosis with review by radiologist | 14 | $3,276 | $234 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days | 38 | $1,998 | $20 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days | 30 | $1,955 | $25 |
| Hospital discharge day management, 30 minutes or less | 30 | $1,741 | $56 |
| Ultrasound evaluation of heart blood vessel or graft with review by radiologist, initial vessel | 17 | $1,409 | $70 |
| Telephonic rhythm strip evaluation of single, dual, multiple lead or leadless pacemaker system, up to 90 days | 14 | $1,275 | $36 |
| External shock to heart to regulate heart beat | 12 | $1,164 | $90 |
| Ultrasound of heart with probe in esophagus, with report | 12 | $1,072 | $82 |
| Evaluation of single, dual, multiple lead or leadless pacemaker system | 25 | $1,034 | $28 |
| Ultrasound of heart, follow-up | 47 | $950 | $19 |
| Evaluation of single, dual, or multiple lead implantable defibrillator system | 11 | $633 | $53 |
| Ultrasound of heart blood flow, valves and chambers | 16 | $293 | $15 |
| Ultrasound of heart blood flow, valves and chambers, follow-up | 47 | $269 | $5 |
| Ultrasound of heart with color-depicted blood flow, rate and valve function | 60 | $196 | $3 |
| Smoking and tobacco use intensive counseling, 4-10 minutes | 14 | $182 | $11 |
| Injection, dipyridamole, per 10 mg | 50 | $156 | None |
| Injection, aminophyllin, up to 250 mg | 52 | $41 | None |
Medicaid work
$166 in 2024
Medicaid paid $166 for 34 billed services this clinician did in 2024, up to 21 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 34 | $166 |
| 2024 | 34 | 1 | 21 | $166 |
| 2022 | 267 | 4 | 29 | $1,664 |
| 2021 | 410 | 3 | 25 | $6,990 |
| 2020 | 125 | 3 | 19 | $1,709 |
| 2019 | 327 | 3 | 40 | $5,488 |
| 2018 | 190 | 3 | 33 | $2,967 |
See the largest Medicaid services in earlier years
2022
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 24 | $898 |
| Return visit (30+ min) | 26 | $509 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 204 | $189 |
| Short return visit (20+ min) | 13 | $69 |
2021
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 81 | $3,938 |
| Return visit (30+ min) | 94 | $2,045 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 235 | $1,006 |
2020
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 98 | $1,087 |
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 14 | $377 |
| Return visit (30+ min) | 13 | $245 |
2019
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 165 | $4,020 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 148 | $1,441 |
| Return visit (30+ min) | 14 | $27 |
2018
| Echocardiography, transthoracic, real-time with image documentation (2D), includes M-mode recording, when performed, complete, with spectral Doppler echocardiography, and with color flow Doppler echocardiography | 102 | $2,584 |
| Return visit (30+ min) | 38 | $304 |
| Electrocardiogram, routine ECG with at least 12 leads; with interpretation and report | 50 | $79 |
Drugs they prescribed that Part D paid
$2,296,332
Pharmacies billed $2,296,332 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 7,275) in 2024. At or below the middle of the specialty; the typical interventional cardiology clinician is at 0%.
5,362 generic and fewer than 11 brand-name prescriptions · $2,296,332 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 388 | $471,383 | $1,215 |
| Entresto | 318 | $331,572 | $1,043 |
| Vyndamax | 12 | $264,144 | $22,012 |
| Farxiga | 235 | $222,756 | $948 |
| Repatha Sureclick | 189 | $198,492 | $1,050 |
See all 74 drugs
| Eliquis | 388 | $471,383 | $1,215 |
| Entresto | 318 | $331,572 | $1,043 |
| Vyndamax | 12 | $264,144 | $22,012 |
| Farxiga | 235 | $222,756 | $948 |
| Repatha Sureclick | 189 | $198,492 | $1,050 |
| Jardiance | 224 | $195,335 | $872 |
| Xarelto | 83 | $92,308 | $1,112 |
| Repatha | 72 | $57,718 | $802 |
| Multaq | 40 | $54,036 | $1,351 |
| Praluent | 47 | $46,053 | $980 |
| Vascepa | 76 | $46,051 | $606 |
| Brilinta | 48 | $30,611 | $638 |
| Rybelsus | 16 | $29,932 | $1,871 |
| Icosapent Ethyl | 55 | $15,612 | $284 |
| Bosentan | 12 | $14,934 | $1,245 |
| Nexlizet | 16 | $14,362 | $898 |
| Ezetimibe | 481 | $13,773 | $29 |
| Rosuvastatin | 524 | $12,744 | $24 |
| Eplerenone | 148 | $10,715 | $72 |
| Edarbi | 14 | $9,363 | $669 |
| Pitavastatin | 12 | $8,565 | $714 |
| Edarbyclor | 11 | $8,288 | $753 |
| Dabigatran Etexilate | 18 | $7,893 | $439 |
| Digoxin | 140 | $7,648 | $55 |
| Inpefa | 12 | $7,106 | $592 |
| Nebivolol | 89 | $6,733 | $76 |
| Colchicine | 45 | $6,667 | $148 |
| Valsartan | 163 | $6,012 | $37 |
| Metoprolol | 458 | $5,555 | $12 |
| Atorvastatin | 392 | $5,045 | $13 |
| Ranolazine Er | 32 | $4,519 | $141 |
| Flecainide Acetate | 77 | $3,682 | $48 |
| Propafenone Hcl Er | 14 | $3,551 | $254 |
| Midodrine | 20 | $3,021 | $151 |
| Losartan | 250 | $2,815 | $11 |
| Diltiazem 24hr Er (Cd) | 78 | $2,797 | $36 |
| Spironolactone-Hctz | 71 | $2,765 | $39 |
| Amlodipine Besylate | 378 | $2,573 | $7 |
| Pravastatin | 148 | $2,538 | $17 |
| Amiodarone | 125 | $2,505 | $20 |
| Sildenafil Citrate | 17 | $2,192 | $129 |
| Torsemide | 118 | $1,903 | $16 |
| Spironolactone | 224 | $1,618 | $7 |
| Carvedilol | 139 | $1,383 | $10 |
| Clopidogrel | 123 | $1,250 | $10 |
| Propafenone | 19 | $1,236 | $65 |
| Isosorbide Mononitrate Er | 60 | $1,037 | $17 |
| Fenofibrate | 14 | $1,018 | $73 |
| Olmesartan Medoxomil | 17 | $945 | $56 |
| Nitroglycerin | 59 | $866 | $15 |
| Hydralazine | 37 | $775 | $21 |
| Hydrochlorothiazide | 75 | $646 | $9 |
| Furosemide | 84 | $634 | $8 |
| Diltiazem 24hr Er | 15 | $616 | $41 |
| Lisinopril | 64 | $591 | $9 |
| Irbesartan | 16 | $509 | $32 |
| Doxazosin Mesylate | 16 | $508 | $32 |
| Celecoxib | 28 | $488 | $17 |
| Verapamil Er | 22 | $409 | $19 |
| Cilostazol | 11 | $399 | $36 |
| Valsartan-Hydrochlorothiazide | 16 | $395 | $25 |
| Clonidine | 41 | $394 | $10 |
| Tamsulosin | 30 | $375 | $12 |
| Labetalol | 13 | $342 | $26 |
| Losartan-Hydrochlorothiazide | 28 | $324 | $12 |
| Pantoprazole | 18 | $267 | $15 |
| Potassium Chloride | 13 | $203 | $16 |
| Metformin Hcl Er | 26 | $202 | $8 |
| Atenolol | 21 | $178 | $8 |
| Metoprolol | 36 | $150 | $4 |
| Omeprazole | 12 | $149 | $12 |
| Warfarin | 15 | $137 | $9 |
| Simvastatin | 20 | $126 | $6 |
| Levothyroxine | 18 | $94 | $5 |
Year by year
| 2024 | 7,275 | 687 | 0% (0) | None | $2,296,332 |
| 2023 | 6,610 | 736 | 0% (0) | 23% | $2,042,275 |
| 2022 | 7,670 | 793 | 0% (0) | 19% | $2,042,274 |
| 2021 | 8,379 | 864 | 0% (0) | 20% | $1,899,615 |
| 2020 | 8,750 | 901 | None | 20% | $1,756,016 |
| 2019 | 7,458 | 748 | None | None | $1,454,725 |
| 2018 | 7,064 | 662 | None | 20% | $1,110,297 |
| 2017 | 7,730 | 673 | None | 23% | $1,083,446 |
| 2016 | 8,474 | 681 | None | None | $1,108,358 |
| 2015 | 8,264 | 650 | None | None | $951,007 |
| 2014 | 7,684 | 648 | None | 29% | $869,016 |
| 2013 | 7,708 | 663 | 0% (19) | 30% | $795,874 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 73 drugs
| Eliquis | 343 | $436,626 | $1,273 |
| Entresto | 245 | $290,252 | $1,185 |
| Farxiga | 167 | $193,509 | $1,159 |
| Repatha Sureclick | 143 | $150,033 | $1,049 |
| Jardiance | 97 | $94,281 | $972 |
| Bosentan | 12 | $92,843 | $7,737 |
| Xarelto | 86 | $92,156 | $1,072 |
| Praluent | 58 | $63,295 | $1,091 |
| Multaq | 39 | $62,511 | $1,603 |
| Ambrisentan | 13 | $58,409 | $4,493 |
| Vascepa | 62 | $41,150 | $664 |
| Rybelsus | 15 | $39,272 | $2,618 |
| Icosapent Ethyl | 58 | $30,415 | $524 |
| Repatha | 30 | $30,238 | $1,008 |
| Brilinta | 37 | $27,570 | $745 |
| Verquvo | 13 | $21,507 | $1,654 |
| Ezetimibe | 440 | $21,047 | $48 |
| Edarbi | 26 | $14,331 | $551 |
| Sildenafil Citrate | 19 | $13,464 | $709 |
| Rosuvastatin | 449 | $13,425 | $30 |
| Edarbyclor | 17 | $10,721 | $631 |
| Nebivolol | 96 | $10,432 | $109 |
| Eplerenone | 113 | $10,178 | $90 |
| Dabigatran Etexilate | 13 | $8,337 | $641 |
| Valsartan | 131 | $6,305 | $48 |
| Atorvastatin | 404 | $6,292 | $16 |
| Metoprolol | 405 | $6,013 | $15 |
| Ranolazine Er | 23 | $4,673 | $203 |
| Colchicine | 23 | $4,296 | $187 |
| Flecainide Acetate | 73 | $4,071 | $56 |
| Losartan | 266 | $3,773 | $14 |
| Diltiazem 24hr Er (Cd) | 82 | $3,441 | $42 |
| Digoxin | 124 | $3,375 | $27 |
| Carvedilol | 172 | $2,902 | $17 |
| Midodrine | 32 | $2,830 | $88 |
| Amlodipine Besylate | 365 | $2,805 | $8 |
| Torsemide | 99 | $2,726 | $28 |
| Pravastatin | 132 | $2,506 | $19 |
| Spironolactone | 176 | $2,254 | $13 |
| Spironolactone-Hctz | 51 | $2,249 | $44 |
| Propafenone | 24 | $2,227 | $93 |
| Amiodarone | 77 | $2,082 | $27 |
| Clopidogrel | 103 | $1,978 | $19 |
| Isosorbide Mononitrate Er | 56 | $1,913 | $34 |
| Celecoxib | 30 | $1,882 | $63 |
| Olmesartan Medoxomil | 23 | $1,881 | $82 |
| Valsartan-Hydrochlorothiazide | 24 | $1,345 | $56 |
| Fenofibrate | 21 | $1,266 | $60 |
| Potassium Chloride | 43 | $1,150 | $27 |
| Hydralazine | 42 | $959 | $23 |
| Irbesartan | 22 | $944 | $43 |
| Pantoprazole | 42 | $935 | $22 |
| Diltiazem 24hr Er | 13 | $838 | $64 |
| Hydrochlorothiazide | 99 | $831 | $8 |
| Furosemide | 94 | $817 | $9 |
| Nitroglycerin | 42 | $780 | $19 |
| Levothyroxine | 26 | $750 | $29 |
| Tamsulosin | 27 | $696 | $26 |
| Clonidine | 60 | $674 | $11 |
| Propranolol | 14 | $659 | $47 |
| Lisinopril | 59 | $652 | $11 |
| Omeprazole | 12 | $594 | $50 |
| Labetalol | 16 | $538 | $34 |
| Warfarin | 20 | $499 | $25 |
| Metoprolol | 47 | $495 | $11 |
| Sotalol | 12 | $403 | $34 |
| Verapamil Er | 13 | $390 | $30 |
| Doxazosin Mesylate | 17 | $337 | $20 |
| Nifedipine Er | 11 | $262 | $24 |
| Atenolol | 23 | $238 | $10 |
| Simvastatin | 20 | $233 | $12 |
| Losartan-Hydrochlorothiazide | 14 | $167 | $12 |
| Metformin | 14 | $156 | $11 |
2022: 79 drugs
| Eliquis | 383 | $494,903 | $1,292 |
| Entresto | 184 | $234,882 | $1,277 |
| Repatha Sureclick | 196 | $194,539 | $993 |
| Ambrisentan | 24 | $150,840 | $6,285 |
| Xarelto | 79 | $98,128 | $1,242 |
| Farxiga | 70 | $93,553 | $1,336 |
| Bosentan | 12 | $85,175 | $7,098 |
| Praluent | 74 | $68,159 | $921 |
| Vascepa | 82 | $54,749 | $668 |
| Icosapent Ethyl | 73 | $47,823 | $655 |
| Multaq | 36 | $47,528 | $1,320 |
| Rybelsus | 17 | $35,726 | $2,102 |
| Ezetimibe | 503 | $34,926 | $69 |
| Rosuvastatin | 517 | $23,584 | $46 |
| Jardiance | 14 | $22,854 | $1,632 |
| Brilinta | 19 | $18,228 | $959 |
| Tadalafil | 14 | $17,866 | $1,276 |
| Edarbyclor | 23 | $14,426 | $627 |
| Ozempic | 12 | $14,407 | $1,201 |
| Edarbi | 29 | $14,102 | $486 |
| Nebivolol | 109 | $13,967 | $128 |
| Eplerenone | 106 | $13,815 | $130 |
| Livalo | 15 | $11,869 | $791 |
| Pradaxa | 14 | $11,450 | $818 |
| Repatha | 13 | $9,375 | $721 |
| Sildenafil Citrate | 11 | $8,056 | $732 |
| Atorvastatin | 541 | $7,808 | $14 |
| Metoprolol | 417 | $7,196 | $17 |
| Valsartan | 156 | $7,124 | $46 |
| Flecainide Acetate | 86 | $6,215 | $72 |
| Losartan | 339 | $4,907 | $14 |
| Diltiazem 24hr Er (Cd) | 70 | $4,805 | $69 |
| Bystolic | 15 | $4,802 | $320 |
| Ranolazine Er | 22 | $4,800 | $218 |
| Digoxin | 135 | $4,498 | $33 |
| Spironolactone-Hctz | 71 | $4,037 | $57 |
| Amlodipine Besylate | 452 | $3,997 | $9 |
| Carvedilol | 237 | $3,552 | $15 |
| Amiodarone | 123 | $2,976 | $24 |
| Clopidogrel | 154 | $2,918 | $19 |
| Celecoxib | 19 | $2,798 | $147 |
| Propafenone | 19 | $2,680 | $141 |
| Spironolactone | 208 | $2,444 | $12 |
| Hydralazine | 63 | $2,331 | $37 |
| Olmesartan Medoxomil | 37 | $2,212 | $60 |
| Pravastatin | 122 | $2,128 | $17 |
| Bumetanide | 13 | $1,996 | $154 |
| Torsemide | 87 | $1,936 | $22 |
| Isosorbide Mononitrate Er | 85 | $1,852 | $22 |
| Fenofibrate | 34 | $1,783 | $52 |
| Synthroid | 22 | $1,778 | $81 |
| Potassium Chloride | 58 | $1,679 | $29 |
| Irbesartan | 24 | $1,292 | $54 |
| Pantoprazole | 62 | $1,170 | $19 |
| Valsartan-Hydrochlorothiazide | 24 | $1,164 | $48 |
| Levothyroxine | 46 | $1,052 | $23 |
| Clonidine | 82 | $987 | $12 |
| Sotalol | 25 | $967 | $39 |
| Furosemide | 122 | $935 | $8 |
| Diltiazem 24hr Er | 19 | $916 | $48 |
| Diltiazem | 23 | $913 | $40 |
| Bisoprolol | 23 | $887 | $39 |
| Metoprolol | 80 | $854 | $11 |
| Lisinopril | 115 | $852 | $7 |
| Dilt-Xr | 16 | $784 | $49 |
| Nitroglycerin | 55 | $756 | $14 |
| Doxazosin Mesylate | 24 | $649 | $27 |
| Hydrochlorothiazide | 115 | $641 | $6 |
| Tamsulosin | 25 | $587 | $23 |
| Warfarin | 28 | $465 | $17 |
| Atenolol | 46 | $460 | $10 |
| Cilostazol | 11 | $454 | $41 |
| Simvastatin | 32 | $395 | $12 |
| Omeprazole | 14 | $339 | $24 |
| Losartan-Hydrochlorothiazide | 23 | $301 | $13 |
| Felodipine Er | 11 | $295 | $27 |
| Metformin | 26 | $255 | $10 |
| Verapamil Er | 15 | $239 | $16 |
| Metformin Hcl Er | 11 | $63 | $6 |
2021: 87 drugs
| Eliquis | 367 | $442,781 | $1,206 |
| Entresto | 181 | $218,071 | $1,205 |
| Repatha Sureclick | 222 | $157,411 | $709 |
| Ambrisentan | 19 | $130,222 | $6,854 |
| Vascepa | 129 | $93,985 | $729 |
| Xarelto | 89 | $92,246 | $1,036 |
| Praluent | 122 | $75,250 | $617 |
| Bosentan | 11 | $60,092 | $5,463 |
| Bystolic | 128 | $52,928 | $414 |
| Farxiga | 37 | $49,014 | $1,325 |
| Multaq | 43 | $48,206 | $1,121 |
| Rybelsus | 33 | $45,887 | $1,391 |
| Ezetimibe | 503 | $34,749 | $69 |
| Rosuvastatin | 467 | $23,642 | $51 |
| Tadalafil | 13 | $21,745 | $1,673 |
| Jardiance | 21 | $20,261 | $965 |
| Brilinta | 16 | $17,717 | $1,107 |
| Eplerenone | 113 | $16,803 | $149 |
| Pradaxa | 24 | $15,953 | $665 |
| Edarbyclor | 24 | $15,129 | $630 |
| Atorvastatin | 702 | $11,772 | $17 |
| Icosapent Ethyl | 21 | $11,013 | $524 |
| Sildenafil Citrate | 15 | $10,922 | $728 |
| Livalo | 13 | $10,085 | $776 |
| Edarbi | 22 | $9,802 | $446 |
| Metoprolol | 389 | $8,442 | $22 |
| Flecainide Acetate | 95 | $8,143 | $86 |
| Valsartan | 123 | $7,330 | $60 |
| Losartan | 423 | $7,222 | $17 |
| Propafenone Hcl Er | 22 | $6,818 | $310 |
| Ranolazine Er | 24 | $6,511 | $271 |
| Diltiazem 24hr Er (Cd) | 90 | $5,724 | $64 |
| Nebivolol | 26 | $5,481 | $211 |
| Propafenone | 41 | $5,205 | $127 |
| Digoxin | 174 | $5,090 | $29 |
| Spironolactone-Hctz | 66 | $3,896 | $59 |
| Carvedilol | 242 | $3,813 | $16 |
| Amiodarone | 140 | $3,692 | $26 |
| Amlodipine Besylate | 430 | $3,564 | $8 |
| Pravastatin | 164 | $3,030 | $18 |
| Synthroid | 36 | $2,992 | $83 |
| Clopidogrel | 202 | $2,911 | $14 |
| Olmesartan Medoxomil | 36 | $2,882 | $80 |
| Spironolactone | 214 | $2,784 | $13 |
| Hydralazine | 107 | $2,723 | $25 |
| Torsemide | 84 | $2,121 | $25 |
| Dilt-Xr | 31 | $1,785 | $58 |
| Isosorbide Mononitrate Er | 96 | $1,775 | $18 |
| Fenofibric Acid | 12 | $1,756 | $146 |
| Midodrine | 20 | $1,686 | $84 |
| Diltiazem 24hr Er | 17 | $1,671 | $98 |
| Olmesartan-Amlodipine-Hctz | 14 | $1,575 | $113 |
| Nitroglycerin | 72 | $1,449 | $20 |
| Pantoprazole | 75 | $1,448 | $19 |
| Potassium Chloride | 51 | $1,309 | $26 |
| Fenofibrate | 27 | $1,221 | $45 |
| Bisoprolol | 20 | $1,168 | $58 |
| Sotalol | 25 | $1,128 | $45 |
| Lisinopril | 146 | $1,099 | $8 |
| Levothyroxine | 41 | $1,079 | $26 |
| Clonidine | 98 | $1,026 | $10 |
| Irbesartan | 22 | $1,014 | $46 |
| Furosemide | 128 | $1,007 | $8 |
| Fludrocortisone Acetate | 16 | $908 | $57 |
| Hydrochlorothiazide | 143 | $867 | $6 |
| Tamsulosin | 27 | $823 | $30 |
| Celecoxib | 22 | $813 | $37 |
| Valsartan-Hydrochlorothiazide | 19 | $806 | $42 |
| Diltiazem | 22 | $742 | $34 |
| Metoprolol | 83 | $738 | $9 |
| Warfarin | 43 | $729 | $17 |
| Losartan-Hydrochlorothiazide | 34 | $705 | $21 |
| Guanfacine | 11 | $610 | $55 |
| Cartia Xt | 14 | $578 | $41 |
| Atenolol | 58 | $572 | $10 |
| Doxazosin Mesylate | 17 | $541 | $32 |
| Propranolol | 12 | $503 | $42 |
| Simvastatin | 42 | $454 | $11 |
| Cilostazol | 12 | $420 | $35 |
| Benazepril | 25 | $364 | $15 |
| Allopurinol | 11 | $309 | $28 |
| Verapamil Er | 14 | $279 | $20 |
| Metformin | 27 | $187 | $7 |
| Omeprazole | 14 | $157 | $11 |
| Ramipril | 14 | $127 | $9 |
| Metformin Hcl Er | 15 | $121 | $8 |
| Amoxicillin | 13 | $18 | $1 |
2020: 83 drugs
| Eliquis | 383 | $407,763 | $1,065 |
| Entresto | 121 | $129,877 | $1,073 |
| Vascepa | 190 | $128,981 | $679 |
| Repatha Sureclick | 206 | $118,836 | $577 |
| Xarelto | 107 | $96,681 | $904 |
| Praluent | 130 | $95,482 | $734 |
| Bosentan | 14 | $78,070 | $5,576 |
| Bystolic | 158 | $57,026 | $361 |
| Multaq | 43 | $52,278 | $1,216 |
| Ezetimibe | 490 | $38,167 | $78 |
| Brilinta | 34 | $31,224 | $918 |
| Sildenafil Citrate | 24 | $20,765 | $865 |
| Rosuvastatin | 357 | $20,764 | $58 |
| Eplerenone | 118 | $17,228 | $146 |
| Atorvastatin | 783 | $16,854 | $22 |
| Pradaxa | 26 | $14,982 | $576 |
| Jardiance | 18 | $14,970 | $832 |
| Edarbyclor | 22 | $12,638 | $574 |
| Metoprolol | 454 | $10,954 | $24 |
| Ranolazine Er | 37 | $10,472 | $283 |
| Livalo | 14 | $10,182 | $727 |
| Flecainide Acetate | 119 | $9,754 | $82 |
| Propafenone Hcl Er | 21 | $8,538 | $407 |
| Losartan | 468 | $7,639 | $16 |
| Edarbi | 15 | $6,775 | $452 |
| Propafenone | 50 | $6,490 | $130 |
| Valsartan | 112 | $6,087 | $54 |
| Diltiazem 24hr Er (Cd) | 88 | $6,024 | $68 |
| Repatha | 14 | $5,882 | $420 |
| Digoxin | 180 | $5,133 | $29 |
| Pravastatin | 201 | $4,613 | $23 |
| Spironolactone-Hctz | 80 | $4,165 | $52 |
| Amiodarone | 110 | $4,046 | $37 |
| Carvedilol | 301 | $3,350 | $11 |
| Amlodipine Besylate | 452 | $3,021 | $7 |
| Clopidogrel | 205 | $2,983 | $15 |
| Fenofibric Acid | 17 | $2,974 | $175 |
| Spironolactone | 239 | $2,690 | $11 |
| Synthroid | 27 | $2,529 | $94 |
| Isosorbide Mononitrate Er | 112 | $2,412 | $22 |
| Losartan-Hydrochlorothiazide | 40 | $2,147 | $54 |
| Dilt-Xr | 36 | $2,050 | $57 |
| Torsemide | 119 | $2,016 | $17 |
| Hydralazine | 104 | $1,927 | $19 |
| Potassium Chloride | 51 | $1,762 | $35 |
| Olmesartan Medoxomil | 34 | $1,642 | $48 |
| Midodrine | 24 | $1,632 | $68 |
| Irbesartan | 48 | $1,610 | $34 |
| Olmesartan-Amlodipine-Hctz | 11 | $1,603 | $146 |
| Diltiazem 24hr Er | 13 | $1,511 | $116 |
| Pantoprazole | 53 | $1,430 | $27 |
| Nitroglycerin | 76 | $1,429 | $19 |
| Verapamil | 11 | $1,427 | $130 |
| Lisinopril | 141 | $1,076 | $8 |
| Tamsulosin | 36 | $1,055 | $29 |
| Telmisartan | 11 | $964 | $88 |
| Furosemide | 131 | $951 | $7 |
| Isosorbide Dinitrate | 13 | $919 | $71 |
| Hydrochlorothiazide | 140 | $824 | $6 |
| Atenolol | 83 | $812 | $10 |
| Warfarin | 58 | $786 | $14 |
| Levothyroxine | 27 | $744 | $28 |
| Sotalol | 18 | $744 | $41 |
| Diltiazem | 27 | $730 | $27 |
| Metoprolol | 104 | $729 | $7 |
| Clonidine | 73 | $701 | $10 |
| Chlorthalidone | 19 | $698 | $37 |
| Valsartan-Hydrochlorothiazide | 23 | $677 | $29 |
| Fenofibrate | 12 | $621 | $52 |
| Fludrocortisone Acetate | 14 | $572 | $41 |
| Guanfacine | 14 | $558 | $40 |
| Verapamil Er | 24 | $496 | $21 |
| Propranolol | 13 | $483 | $37 |
| Cartia Xt | 21 | $455 | $22 |
| Simvastatin | 49 | $449 | $9 |
| Allopurinol | 12 | $344 | $29 |
| Ramipril | 23 | $231 | $10 |
| Benazepril | 17 | $217 | $13 |
| Metformin Hcl Er | 14 | $187 | $13 |
| Metformin | 29 | $164 | $6 |
| Meclizine | 12 | $114 | $9 |
| Omeprazole | 12 | $107 | $9 |
| Amoxicillin | 14 | $13 | $1 |
2019: 78 drugs
| Eliquis | 291 | $291,187 | $1,001 |
| Praluent | 125 | $134,463 | $1,076 |
| Entresto | 89 | $87,264 | $980 |
| Repatha Sureclick | 115 | $84,411 | $734 |
| Xarelto | 90 | $75,087 | $834 |
| Vascepa | 102 | $66,959 | $656 |
| Bystolic | 145 | $48,830 | $337 |
| Brilinta | 55 | $47,276 | $860 |
| Multaq | 32 | $42,605 | $1,331 |
| Ezetimibe | 380 | $30,421 | $80 |
| Rosuvastatin | 333 | $19,945 | $60 |
| Atorvastatin | 689 | $19,217 | $28 |
| Sildenafil Citrate | 14 | $15,831 | $1,131 |
| Jardiance | 12 | $15,599 | $1,300 |
| Ranolazine Er | 34 | $14,999 | $441 |
| Eplerenone | 101 | $14,322 | $142 |
| Tradjenta | 11 | $12,937 | $1,176 |
| Janumet | 11 | $11,496 | $1,045 |
| Metoprolol | 369 | $11,090 | $30 |
| Januvia | 11 | $10,917 | $992 |
| Lipitor | 11 | $10,543 | $958 |
| Edarbyclor | 22 | $10,187 | $463 |
| Pradaxa | 12 | $7,361 | $613 |
| Flecainide Acetate | 78 | $6,667 | $85 |
| Losartan | 416 | $5,927 | $14 |
| Valsartan | 83 | $5,842 | $70 |
| Digoxin | 138 | $4,852 | $35 |
| Propafenone | 43 | $4,461 | $104 |
| Pravastatin | 163 | $4,406 | $27 |
| Amiodarone | 88 | $3,793 | $43 |
| Diltiazem 24hr Er (Cd) | 82 | $3,288 | $40 |
| Fenofibric Acid | 15 | $3,281 | $219 |
| Spironolactone-Hctz | 81 | $3,177 | $39 |
| Carvedilol | 245 | $3,127 | $13 |
| Amlodipine Besylate | 391 | $3,083 | $8 |
| Isosorbide Mononitrate Er | 111 | $2,982 | $27 |
| Spironolactone | 232 | $2,839 | $12 |
| Clopidogrel | 142 | $2,610 | $18 |
| Midodrine | 22 | $2,183 | $99 |
| Dilt-Xr | 36 | $1,956 | $54 |
| Torsemide | 110 | $1,955 | $18 |
| Diltiazem 24hr Er | 20 | $1,951 | $98 |
| Irbesartan | 42 | $1,866 | $44 |
| Synthroid | 15 | $1,725 | $115 |
| Sotalol | 40 | $1,582 | $40 |
| Potassium Chloride | 45 | $1,555 | $35 |
| Hydralazine | 92 | $1,534 | $17 |
| Nitroglycerin | 88 | $1,454 | $17 |
| Losartan-Hydrochlorothiazide | 83 | $1,429 | $17 |
| Olmesartan Medoxomil | 24 | $1,428 | $60 |
| Pantoprazole | 48 | $1,030 | $21 |
| Warfarin | 68 | $1,010 | $15 |
| Atenolol | 73 | $1,008 | $14 |
| Lisinopril | 119 | $964 | $8 |
| Celecoxib | 18 | $957 | $53 |
| Irbesartan-Hydrochlorothiazide | 13 | $952 | $73 |
| Furosemide | 116 | $918 | $8 |
| Hydrochlorothiazide | 101 | $794 | $8 |
| Tamsulosin | 24 | $773 | $32 |
| Metoprolol | 90 | $718 | $8 |
| Diltiazem | 31 | $657 | $21 |
| Cartia Xt | 17 | $553 | $33 |
| Propranolol | 15 | $525 | $35 |
| Levothyroxine | 23 | $523 | $23 |
| Digitek | 27 | $439 | $16 |
| Guanfacine | 15 | $404 | $27 |
| Digox | 12 | $385 | $32 |
| Clonidine | 47 | $382 | $8 |
| Ramipril | 30 | $346 | $12 |
| Cilostazol | 11 | $335 | $30 |
| Simvastatin | 33 | $324 | $10 |
| Quinapril | 12 | $316 | $26 |
| Valsartan-Hydrochlorothiazide | 13 | $302 | $23 |
| Famotidine | 21 | $261 | $12 |
| Metformin | 25 | $162 | $6 |
| Benazepril | 14 | $148 | $11 |
| Omeprazole | 14 | $134 | $10 |
| Amoxicillin | 16 | $21 | $1 |
2018: 77 drugs
| Eliquis | 259 | $208,471 | $805 |
| Praluent | 96 | $125,983 | $1,312 |
| Entresto | 86 | $78,283 | $910 |
| Repatha Sureclick | 58 | $72,754 | $1,254 |
| Xarelto | 76 | $52,913 | $696 |
| Ezetimibe | 317 | $46,952 | $148 |
| Brilinta | 62 | $46,180 | $745 |
| Multaq | 32 | $37,686 | $1,178 |
| Ranexa | 45 | $34,721 | $772 |
| Bystolic | 135 | $34,040 | $252 |
| Januvia | 22 | $22,443 | $1,020 |
| Atorvastatin | 726 | $18,813 | $26 |
| Dofetilide | 11 | $17,940 | $1,631 |
| Rosuvastatin | 296 | $15,849 | $54 |
| Eplerenone | 99 | $15,271 | $154 |
| Pradaxa | 12 | $13,766 | $1,147 |
| Edarbyclor | 43 | $13,081 | $304 |
| Metoprolol | 325 | $11,036 | $34 |
| Vascepa | 24 | $9,286 | $387 |
| Prasugrel | 18 | $7,169 | $398 |
| Flecainide Acetate | 78 | $6,121 | $78 |
| Digoxin | 132 | $6,016 | $46 |
| Edarbi | 15 | $5,698 | $380 |
| Losartan | 388 | $5,190 | $13 |
| Pravastatin | 188 | $5,156 | $27 |
| Diltiazem 12hr Er | 16 | $4,404 | $275 |
| Propafenone | 33 | $4,301 | $130 |
| Fenofibric Acid | 21 | $4,100 | $195 |
| Spironolactone-Hctz | 80 | $3,585 | $45 |
| Valsartan | 70 | $3,197 | $46 |
| Spironolactone | 219 | $3,042 | $14 |
| Isosorbide Mononitrate Er | 114 | $3,040 | $27 |
| Celecoxib | 33 | $2,965 | $90 |
| Amiodarone | 130 | $2,880 | $22 |
| Clopidogrel | 125 | $2,705 | $22 |
| Amlodipine Besylate | 319 | $2,541 | $8 |
| Potassium Chloride | 44 | $2,425 | $55 |
| Carvedilol | 246 | $2,330 | $9 |
| Plavix | 12 | $2,219 | $185 |
| Nifedipine Er | 19 | $2,216 | $117 |
| Cartia Xt | 59 | $2,184 | $37 |
| Torsemide | 130 | $2,102 | $16 |
| Diltiazem 24hr Er (Cd) | 62 | $2,081 | $34 |
| Sotalol | 24 | $1,810 | $75 |
| Digox | 29 | $1,783 | $61 |
| Synthroid | 18 | $1,729 | $96 |
| Omega-3 Acid Ethyl Esters | 12 | $1,524 | $127 |
| Losartan-Hydrochlorothiazide | 94 | $1,487 | $16 |
| Warfarin | 94 | $1,440 | $15 |
| Diltiazem 24hr Er | 18 | $1,427 | $79 |
| Irbesartan | 42 | $1,426 | $34 |
| Dilt-Xr | 25 | $1,403 | $56 |
| Nitroglycerin | 73 | $1,274 | $17 |
| Hydralazine | 49 | $1,204 | $25 |
| Furosemide | 141 | $1,044 | $7 |
| Cilostazol | 17 | $925 | $54 |
| Irbesartan-Hydrochlorothiazide | 18 | $857 | $48 |
| Metoprolol | 104 | $831 | $8 |
| Tamsulosin | 20 | $822 | $41 |
| Valsartan-Hydrochlorothiazide | 23 | $796 | $35 |
| Pantoprazole | 60 | $778 | $13 |
| Lisinopril | 86 | $698 | $8 |
| Atenolol | 65 | $685 | $11 |
| Allopurinol | 19 | $664 | $35 |
| Levothyroxine | 34 | $644 | $19 |
| Hydrochlorothiazide | 86 | $489 | $6 |
| Ramipril | 27 | $426 | $16 |
| Diltiazem | 27 | $379 | $14 |
| Bisoprolol | 15 | $355 | $24 |
| Digitek | 12 | $329 | $27 |
| Omeprazole | 17 | $286 | $17 |
| Triamterene-Hydrochlorothiazid | 18 | $278 | $15 |
| Simvastatin | 26 | $261 | $10 |
| Clonidine | 37 | $254 | $7 |
| Famotidine | 26 | $186 | $7 |
| Metformin | 17 | $182 | $11 |
| Benazepril | 15 | $116 | $8 |
2017: 85 drugs
| Eliquis | 274 | $179,382 | $655 |
| Praluent | 49 | $78,305 | $1,598 |
| Zetia | 92 | $63,555 | $691 |
| Brilinta | 81 | $50,904 | $628 |
| Ezetimibe | 190 | $49,686 | $262 |
| Xarelto | 70 | $47,942 | $685 |
| Entresto | 60 | $43,271 | $721 |
| Bystolic | 192 | $38,558 | $201 |
| Repatha Sureclick | 23 | $33,337 | $1,449 |
| Effient | 44 | $32,052 | $728 |
| Ranexa | 47 | $30,617 | $651 |
| Multaq | 24 | $26,869 | $1,120 |
| Pradaxa | 23 | $23,934 | $1,041 |
| Rosuvastatin | 285 | $19,143 | $67 |
| Atorvastatin | 830 | $18,708 | $23 |
| Eplerenone | 93 | $15,867 | $171 |
| Sildenafil | 18 | $14,720 | $818 |
| Januvia | 13 | $14,509 | $1,116 |
| Dofetilide | 12 | $12,185 | $1,015 |
| Propafenone Hcl Er | 15 | $10,449 | $697 |
| Metoprolol | 321 | $9,339 | $29 |
| Crestor | 15 | $8,716 | $581 |
| Tradjenta | 12 | $8,382 | $698 |
| Prasugrel | 12 | $8,338 | $695 |
| Coreg Cr | 11 | $8,067 | $733 |
| Flecainide Acetate | 73 | $7,948 | $109 |
| Livalo | 12 | $7,057 | $588 |
| Edarbyclor | 29 | $6,264 | $216 |
| Valsartan | 146 | $6,015 | $41 |
| Pravastatin | 235 | $5,695 | $24 |
| Digoxin | 128 | $5,058 | $40 |
| Fenofibric Acid | 24 | $4,921 | $205 |
| Spironolactone-Hctz | 118 | $4,807 | $41 |
| Losartan | 393 | $4,764 | $12 |
| Chantix | 11 | $4,375 | $398 |
| Potassium Chloride | 82 | $3,791 | $46 |
| Tekturna | 13 | $3,442 | $265 |
| Amiodarone | 158 | $3,308 | $21 |
| Celecoxib | 28 | $3,047 | $109 |
| Amlodipine Besylate | 393 | $2,619 | $7 |
| Spironolactone | 235 | $2,492 | $11 |
| Clopidogrel | 144 | $2,460 | $17 |
| Propafenone | 25 | $2,289 | $92 |
| Carvedilol | 304 | $2,284 | $8 |
| Isosorbide Mononitrate Er | 124 | $2,261 | $18 |
| Diltiazem 24hr Er | 82 | $2,165 | $26 |
| Plavix | 13 | $2,159 | $166 |
| Nifedipine Er | 18 | $2,027 | $113 |
| Digox | 31 | $1,995 | $64 |
| Isosorbide Dinitrate | 20 | $1,963 | $98 |
| Warfarin | 143 | $1,806 | $13 |
| Cilostazol | 40 | $1,735 | $43 |
| Cartia Xt | 48 | $1,707 | $36 |
| Nitroglycerin | 62 | $1,564 | $25 |
| Torsemide | 131 | $1,550 | $12 |
| Dilt-Xr | 22 | $1,351 | $61 |
| Hydralazine | 60 | $1,278 | $21 |
| Fenofibrate | 14 | $1,250 | $89 |
| Valsartan-Hydrochlorothiazide | 35 | $1,230 | $35 |
| Synthroid | 12 | $1,185 | $99 |
| Irbesartan | 30 | $968 | $32 |
| Losartan-Hydrochlorothiazide | 77 | $967 | $13 |
| Sotalol | 40 | $939 | $23 |
| Digitek | 32 | $918 | $29 |
| Furosemide | 146 | $886 | $6 |
| Levothyroxine | 43 | $864 | $20 |
| Metoprolol | 120 | $716 | $6 |
| Atenolol | 78 | $682 | $9 |
| Lisinopril | 109 | $679 | $6 |
| Pantoprazole | 71 | $626 | $9 |
| Diltiazem | 24 | $598 | $25 |
| Allopurinol | 29 | $491 | $17 |
| Hydrochlorothiazide | 69 | $468 | $7 |
| Bisoprolol | 14 | $418 | $30 |
| Ramipril | 26 | $412 | $16 |
| Tamsulosin | 15 | $388 | $26 |
| Omeprazole | 17 | $371 | $22 |
| Midodrine | 13 | $361 | $28 |
| Triamterene-Hydrochlorothiazid | 19 | $352 | $19 |
| Simvastatin | 42 | $275 | $7 |
| Bisoprolol-Hydrochlorothiazide | 12 | $256 | $21 |
| Clonidine | 51 | $212 | $4 |
| Metformin | 24 | $205 | $9 |
| Benazepril | 23 | $188 | $8 |
| Famotidine | 18 | $157 | $9 |
2016: 90 drugs
| Eliquis | 238 | $148,050 | $622 |
| Zetia | 221 | $139,482 | $631 |
| Crestor | 181 | $87,875 | $485 |
| Brilinta | 127 | $55,842 | $440 |
| Xarelto | 81 | $46,115 | $569 |
| Bystolic | 203 | $39,009 | $192 |
| Ranexa | 63 | $33,704 | $535 |
| Multaq | 30 | $33,275 | $1,109 |
| Praluent | 18 | $29,455 | $1,636 |
| Atorvastatin | 982 | $26,584 | $27 |
| Effient | 38 | $23,044 | $606 |
| Tikosyn | 15 | $21,349 | $1,423 |
| Januvia | 22 | $20,698 | $941 |
| Pradaxa | 19 | $19,859 | $1,045 |
| Repatha Sureclick | 18 | $19,665 | $1,092 |
| Entresto | 23 | $13,560 | $590 |
| Valsartan | 126 | $12,894 | $102 |
| Rosuvastatin | 84 | $11,440 | $136 |
| Coreg Cr | 17 | $11,361 | $668 |
| Eplerenone | 88 | $11,216 | $127 |
| Metoprolol | 332 | $9,068 | $27 |
| Tribenzor | 19 | $7,552 | $397 |
| Pravastatin | 287 | $6,819 | $24 |
| Propafenone Hcl Er | 11 | $5,693 | $518 |
| Livalo | 17 | $5,395 | $317 |
| Spironolactone-Hctz | 134 | $5,018 | $37 |
| Digoxin | 140 | $4,924 | $35 |
| Fenofibric Acid | 29 | $4,910 | $169 |
| Flecainide Acetate | 80 | $4,297 | $54 |
| Losartan | 426 | $4,224 | $10 |
| Tekturna | 15 | $4,116 | $274 |
| Onglyza | 11 | $3,985 | $362 |
| Diltiazem 24hr Er | 125 | $3,759 | $30 |
| Potassium Chloride | 67 | $3,045 | $45 |
| Amiodarone | 115 | $2,831 | $25 |
| Amlodipine Besylate | 403 | $2,780 | $7 |
| Spironolactone | 256 | $2,757 | $11 |
| Clopidogrel | 160 | $2,678 | $17 |
| Digox | 61 | $2,481 | $41 |
| Warfarin | 170 | $2,455 | $14 |
| Carvedilol | 326 | $2,444 | $7 |
| Cartia Xt | 45 | $2,281 | $51 |
| Fenofibrate | 19 | $2,212 | $116 |
| Isosorbide Mononitrate Er | 126 | $2,026 | $16 |
| Plavix | 12 | $1,971 | $164 |
| Propafenone | 27 | $1,963 | $73 |
| Matzim La | 12 | $1,726 | $144 |
| Hydralazine | 102 | $1,626 | $16 |
| Midodrine | 15 | $1,605 | $107 |
| Diltiazem 24hr Cd | 39 | $1,597 | $41 |
| Isosorbide Dinitrate | 28 | $1,564 | $56 |
| Nitrostat | 49 | $1,534 | $31 |
| Torsemide | 120 | $1,473 | $12 |
| Losartan-Hydrochlorothiazide | 88 | $1,288 | $15 |
| Valsartan-Hydrochlorothiazide | 53 | $1,237 | $23 |
| Lisinopril | 183 | $1,170 | $6 |
| Sildenafil | 20 | $1,133 | $57 |
| Irbesartan | 36 | $1,015 | $28 |
| Dilt-Xr | 24 | $1,013 | $42 |
| Levothyroxine | 46 | $995 | $22 |
| Ramipril | 42 | $988 | $24 |
| Cilostazol | 15 | $934 | $62 |
| Atenolol | 106 | $872 | $8 |
| Toprol Xl | 17 | $861 | $51 |
| Bisoprolol | 17 | $777 | $46 |
| Omeprazole | 38 | $775 | $20 |
| Metoprolol | 156 | $751 | $5 |
| Sotalol | 41 | $747 | $18 |
| Nifedipine Er | 12 | $726 | $60 |
| Allopurinol | 37 | $725 | $20 |
| Diltiazem Er | 12 | $708 | $59 |
| Furosemide | 146 | $708 | $5 |
| Diltiazem | 30 | $666 | $22 |
| Hydrochlorothiazide | 98 | $662 | $7 |
| Tamsulosin | 16 | $569 | $36 |
| Taztia Xt | 12 | $540 | $45 |
| Pantoprazole | 66 | $520 | $8 |
| Simvastatin | 65 | $459 | $7 |
| Sotalol Af | 11 | $448 | $41 |
| Bisoprolol-Hydrochlorothiazide | 16 | $434 | $27 |
| Clonidine | 69 | $427 | $6 |
| Digitek | 19 | $393 | $21 |
| Irbesartan-Hydrochlorothiazide | 11 | $382 | $35 |
| Doxazosin Mesylate | 22 | $372 | $17 |
| Famotidine | 36 | $358 | $10 |
| Triamterene-Hydrochlorothiazid | 20 | $281 | $14 |
| Metformin | 26 | $271 | $10 |
| Nitroglycerin | 14 | $262 | $19 |
| Benazepril | 25 | $232 | $9 |
| Escitalopram | 11 | $64 | $6 |
2015: 96 drugs
| Tracleer | 13 | $112,008 | $8,616 |
| Zetia | 225 | $105,059 | $467 |
| Crestor | 234 | $101,782 | $435 |
| Eliquis | 174 | $85,062 | $489 |
| Brilinta | 106 | $38,134 | $360 |
| Multaq | 41 | $37,759 | $921 |
| Xarelto | 79 | $36,870 | $467 |
| Ranexa | 70 | $36,593 | $523 |
| Bystolic | 187 | $30,685 | $164 |
| Atorvastatin | 900 | $26,251 | $29 |
| Januvia | 26 | $18,608 | $716 |
| Valsartan | 102 | $16,709 | $164 |
| Tikosyn | 23 | $16,408 | $713 |
| Effient | 34 | $15,817 | $465 |
| Pradaxa | 18 | $15,636 | $869 |
| Tradjenta | 31 | $13,970 | $451 |
| Metoprolol | 328 | $10,520 | $32 |
| Pravastatin | 288 | $8,265 | $29 |
| Tribenzor | 22 | $7,382 | $336 |
| Digoxin | 164 | $6,730 | $41 |
| Eplerenone | 48 | $6,218 | $130 |
| Diltiazem 24hr Er | 90 | $5,869 | $65 |
| Procardia Xl | 12 | $5,850 | $488 |
| Livalo | 28 | $5,541 | $198 |
| Janumet | 11 | $5,444 | $495 |
| Propafenone Hcl Er | 11 | $5,382 | $489 |
| Coreg Cr | 13 | $5,119 | $394 |
| Spironolactone-Hctz | 105 | $4,019 | $38 |
| Onglyza | 12 | $3,965 | $330 |
| Edarbi | 11 | $3,871 | $352 |
| Losartan | 362 | $3,844 | $11 |
| Valsartan-Hydrochlorothiazide | 83 | $3,729 | $45 |
| Warfarin | 197 | $3,696 | $19 |
| Fenofibric Acid | 15 | $3,684 | $246 |
| Tekturna | 15 | $3,682 | $245 |
| Digox | 100 | $3,678 | $37 |
| Coumadin | 17 | $3,242 | $191 |
| Flecainide Acetate | 67 | $3,187 | $48 |
| Zontivity | 11 | $2,976 | $271 |
| Clopidogrel | 154 | $2,788 | $18 |
| Fenofibrate | 27 | $2,759 | $102 |
| Potassium Chloride | 61 | $2,551 | $42 |
| Cartia Xt | 58 | $2,390 | $41 |
| Amlodipine Besylate | 384 | $2,233 | $6 |
| Carvedilol | 276 | $2,183 | $8 |
| Isosorbide Mononitrate Er | 123 | $2,160 | $18 |
| Spironolactone | 266 | $2,159 | $8 |
| Benicar | 13 | $2,117 | $163 |
| Diltiazem 24hr Cd | 49 | $1,892 | $39 |
| Propafenone | 51 | $1,669 | $33 |
| Isosorbide Dinitrate | 27 | $1,602 | $59 |
| Hydralazine | 108 | $1,404 | $13 |
| Nitrostat | 64 | $1,402 | $22 |
| Diltiazem Er | 37 | $1,298 | $35 |
| Midodrine | 15 | $1,249 | $83 |
| Amiodarone | 97 | $1,242 | $13 |
| Metoprolol | 198 | $1,119 | $6 |
| Ramipril | 48 | $1,057 | $22 |
| Lisinopril | 212 | $1,050 | $5 |
| Cilostazol | 23 | $1,039 | $45 |
| Levothyroxine | 43 | $952 | $22 |
| Losartan-Hydrochlorothiazide | 84 | $947 | $11 |
| Irbesartan | 34 | $923 | $27 |
| Irbesartan-Hydrochlorothiazide | 18 | $864 | $48 |
| Torsemide | 71 | $857 | $12 |
| Amlodipine Besylate-Benazepril | 16 | $853 | $53 |
| Atenolol | 114 | $815 | $7 |
| Sotalol | 44 | $806 | $18 |
| Furosemide | 173 | $802 | $5 |
| Nifedipine Er | 12 | $688 | $57 |
| Digitek | 23 | $687 | $30 |
| Sildenafil | 12 | $686 | $57 |
| Pantoprazole | 78 | $670 | $9 |
| Hydrochlorothiazide | 83 | $654 | $8 |
| Dilt-Xr | 15 | $649 | $43 |
| Simvastatin | 97 | $639 | $7 |
| Diltiazem | 25 | $625 | $25 |
| Allopurinol | 24 | $622 | $26 |
| Pioglitazone | 12 | $617 | $51 |
| Bisoprolol | 14 | $591 | $42 |
| Propranolol Hcl Er | 13 | $559 | $43 |
| Triamterene-Hydrochlorothiazid | 28 | $504 | $18 |
| Quinapril | 12 | $481 | $40 |
| Omeprazole | 29 | $474 | $16 |
| Verapamil Er | 14 | $462 | $33 |
| Clonidine | 87 | $448 | $5 |
| Doxazosin Mesylate | 16 | $409 | $26 |
| Sotalol Af | 12 | $345 | $29 |
| Famotidine | 31 | $324 | $10 |
| Bisoprolol-Hydrochlorothiazide | 14 | $307 | $22 |
| Tamsulosin | 13 | $302 | $23 |
| Klor-Con M20 | 11 | $287 | $26 |
| Gabapentin | 17 | $231 | $14 |
| Benazepril | 18 | $213 | $12 |
| Glimepiride | 13 | $195 | $15 |
| Metformin | 28 | $193 | $7 |
2014: 87 drugs
| Tracleer | 13 | $99,645 | $7,665 |
| Crestor | 229 | $85,634 | $374 |
| Zetia | 205 | $78,731 | $384 |
| Ranexa | 96 | $50,188 | $523 |
| Xarelto | 103 | $49,011 | $476 |
| Eliquis | 110 | $48,719 | $443 |
| Multaq | 64 | $41,987 | $656 |
| Bystolic | 178 | $26,593 | $149 |
| Atorvastatin | 739 | $23,997 | $32 |
| Diovan | 92 | $23,032 | $250 |
| Tradjenta | 55 | $20,926 | $380 |
| Brilinta | 68 | $18,924 | $278 |
| Januvia | 26 | $17,914 | $689 |
| Effient | 30 | $14,871 | $496 |
| Pradaxa | 20 | $12,928 | $646 |
| Valsartan | 32 | $10,336 | $323 |
| Metoprolol | 260 | $9,482 | $36 |
| Digoxin | 182 | $8,344 | $46 |
| Eplerenone | 55 | $8,339 | $152 |
| Valsartan-Hydrochlorothiazide | 103 | $8,286 | $80 |
| Tribenzor | 35 | $8,053 | $230 |
| Pravastatin | 208 | $7,762 | $37 |
| Amlodipine-Atorvastatin | 12 | $6,882 | $573 |
| Losartan | 297 | $4,960 | $17 |
| Clopidogrel | 180 | $4,516 | $25 |
| Livalo | 28 | $4,420 | $158 |
| Midodrine | 28 | $4,233 | $151 |
| Digox | 100 | $4,158 | $42 |
| Flecainide Acetate | 71 | $3,969 | $56 |
| Fenofibrate | 34 | $3,875 | $114 |
| Diltiazem 24hr Er | 88 | $3,854 | $44 |
| Edarbi | 12 | $3,656 | $305 |
| Spironolactone-Hctz | 103 | $3,642 | $35 |
| Warfarin | 234 | $3,308 | $14 |
| Carvedilol | 270 | $3,049 | $11 |
| Amlodipine Besylate | 312 | $2,523 | $8 |
| Hydralazine | 128 | $2,500 | $20 |
| Fenofibrate | 16 | $2,371 | $148 |
| Potassium Chloride | 61 | $2,342 | $38 |
| Spironolactone | 199 | $2,186 | $11 |
| Isosorbide Mononitrate Er | 108 | $2,157 | $20 |
| Matzim La | 11 | $2,054 | $187 |
| Cilostazol | 51 | $2,051 | $40 |
| Diltiazem 24hr Cd | 56 | $1,826 | $33 |
| Diltiazem Er | 43 | $1,741 | $40 |
| Sotalol | 58 | $1,695 | $29 |
| Propafenone | 31 | $1,631 | $53 |
| Nitrostat | 86 | $1,610 | $19 |
| Amlodipine Besylate-Benazepril | 16 | $1,566 | $98 |
| Coumadin | 14 | $1,562 | $112 |
| Ramipril | 66 | $1,469 | $22 |
| Diltiazem 12hr Er | 11 | $1,451 | $132 |
| Lisinopril | 204 | $1,428 | $7 |
| Klor-Con 10 | 12 | $1,372 | $114 |
| Cartia Xt | 18 | $1,277 | $71 |
| Irbesartan | 28 | $1,221 | $44 |
| Amiodarone | 89 | $1,144 | $13 |
| Losartan-Hydrochlorothiazide | 65 | $1,143 | $18 |
| Levothyroxine | 48 | $1,053 | $22 |
| Atenolol | 130 | $1,040 | $8 |
| Furosemide | 197 | $1,040 | $5 |
| Torsemide | 37 | $975 | $26 |
| Omeprazole | 42 | $974 | $23 |
| Irbesartan-Hydrochlorothiazide | 18 | $861 | $48 |
| Isosorbide Dinitrate | 15 | $800 | $53 |
| Simvastatin | 78 | $751 | $10 |
| Verapamil Er | 20 | $727 | $36 |
| Metoprolol | 117 | $724 | $6 |
| Pantoprazole | 53 | $648 | $12 |
| Clonidine | 97 | $599 | $6 |
| Propranolol Hcl Er | 13 | $544 | $42 |
| Doxazosin Mesylate | 16 | $497 | $31 |
| Quinapril | 12 | $484 | $40 |
| Klor-Con M20 | 17 | $479 | $28 |
| Hydrochlorothiazide | 95 | $455 | $5 |
| Pyridostigmine | 12 | $443 | $37 |
| Terazosin | 14 | $376 | $27 |
| Famotidine | 32 | $360 | $11 |
| Allopurinol | 30 | $339 | $11 |
| Triamterene-Hydrochlorothiazid | 13 | $314 | $24 |
| Tamsulosin | 15 | $302 | $20 |
| Metformin | 34 | $290 | $9 |
| Ranitidine | 16 | $262 | $16 |
| Lovastatin | 14 | $261 | $19 |
| Glimepiride | 11 | $209 | $19 |
| Pacerone | 11 | $180 | $16 |
| Gabapentin | 13 | $145 | $11 |
2013: 93 drugs
| Crestor | 244 | $76,383 | $313 |
| Tracleer | 11 | $75,503 | $6,864 |
| Zetia | 202 | $62,774 | $311 |
| Xarelto | 121 | $44,871 | $371 |
| Diovan | 145 | $35,085 | $242 |
| Atorvastatin | 744 | $33,926 | $46 |
| Multaq | 57 | $32,737 | $574 |
| Ranexa | 62 | $31,626 | $510 |
| Bystolic | 219 | $26,040 | $119 |
| Sildenafil | 22 | $20,420 | $928 |
| Pradaxa | 41 | $19,741 | $481 |
| Januvia | 36 | $17,703 | $492 |
| Tradjenta | 53 | $16,946 | $320 |
| Valsartan-Hydrochlorothiazide | 83 | $13,939 | $168 |
| Eliquis | 30 | $12,898 | $430 |
| Metoprolol | 313 | $12,559 | $40 |
| Effient | 40 | $11,856 | $296 |
| Clopidogrel | 221 | $10,278 | $47 |
| Brilinta | 36 | $9,457 | $263 |
| Eplerenone | 64 | $8,025 | $125 |
| Exforge | 21 | $7,670 | $365 |
| Nisoldipine | 14 | $7,267 | $519 |
| Losartan | 298 | $7,071 | $24 |
| Aggrenox | 13 | $6,070 | $467 |
| Midodrine | 22 | $5,016 | $228 |
| Niaspan | 12 | $4,991 | $416 |
| Flecainide Acetate | 81 | $4,841 | $60 |
| Pravastatin | 214 | $4,753 | $22 |
| Warfarin | 262 | $4,530 | $17 |
| Carvedilol | 284 | $4,094 | $14 |
| Diltiazem Er | 68 | $3,979 | $59 |
| Irbesartan | 42 | $3,639 | $87 |
| Propafenone | 33 | $3,638 | $110 |
| Diltiazem 24hr Er | 84 | $3,632 | $43 |
| Fenofibrate | 34 | $3,486 | $103 |
| Hydralazine | 119 | $3,483 | $29 |
| Janumet Xr | 13 | $3,335 | $257 |
| Amlodipine Besylate | 309 | $3,116 | $10 |
| Fenofibrate | 12 | $3,111 | $259 |
| Potassium Chloride | 61 | $3,037 | $50 |
| Coreg Cr | 12 | $3,007 | $251 |
| Isosorbide Mononitrate Er | 101 | $2,973 | $29 |
| Livalo | 19 | $2,875 | $151 |
| Matzim La | 14 | $2,730 | $195 |
| Edarbi | 21 | $2,702 | $129 |
| Amlodipine Besylate-Benazepril | 18 | $2,672 | $148 |
| Spironolactone-Hctz | 110 | $2,498 | $23 |
| Tribenzor | 13 | $2,354 | $181 |
| Spironolactone | 155 | $2,217 | $14 |
| Diltiazem 24hr Cd | 41 | $2,148 | $52 |
| Lisinopril | 233 | $2,066 | $9 |
| Colcrys | 12 | $1,713 | $143 |
| Edarbyclor | 16 | $1,678 | $105 |
| Cilostazol | 52 | $1,655 | $32 |
| Simvastatin | 114 | $1,594 | $14 |
| Digox | 145 | $1,586 | $11 |
| Ramipril | 60 | $1,509 | $25 |
| Isosorbide Dinitrate | 15 | $1,323 | $88 |
| Torsemide | 25 | $1,310 | $52 |
| Nifedipine Er | 16 | $1,295 | $81 |
| Losartan-Hydrochlorothiazide | 61 | $1,235 | $20 |
| Sotalol | 31 | $1,193 | $38 |
| Coumadin | 16 | $1,151 | $72 |
| Irbesartan-Hydrochlorothiazide | 15 | $1,134 | $76 |
| Omeprazole | 47 | $1,118 | $24 |
| Amiodarone | 44 | $1,102 | $25 |
| Digoxin | 117 | $1,093 | $9 |
| Nitrostat | 67 | $950 | $14 |
| Verapamil Er | 21 | $933 | $44 |
| Furosemide | 165 | $933 | $6 |
| Atenolol | 122 | $917 | $8 |
| Hydrochlorothiazide | 113 | $729 | $6 |
| Pantoprazole | 43 | $702 | $16 |
| Metoprolol | 99 | $683 | $7 |
| Clonidine | 106 | $617 | $6 |
| Propranolol | 30 | $571 | $19 |
| Pyridostigmine | 17 | $556 | $33 |
| Lovastatin | 20 | $520 | $26 |
| Quinapril | 27 | $491 | $18 |
| Tamsulosin | 11 | $373 | $34 |
| Ranitidine | 19 | $368 | $19 |
| Pacerone | 24 | $351 | $15 |
| Levothyroxine | 28 | $350 | $13 |
| Klor-Con M20 | 15 | $348 | $23 |
| Doxazosin Mesylate | 17 | $331 | $19 |
| Klor-Con 8 | 15 | $293 | $20 |
| Metformin | 40 | $267 | $7 |
| Hydrocodone-Acetaminophen | 17 | $211 | $12 |
| Famotidine | 28 | $204 | $7 |
| Allopurinol | 18 | $193 | $11 |
| Glimepiride | 11 | $190 | $17 |
| Enalapril Maleate | 17 | $169 | $10 |
| Benazepril | 13 | $155 | $12 |
Money from drug and device companies
$11,865 in 2025
| 2025 | 5 | 45 | $9,568 | $11,865 |
| 2024 | 7 | 37 | $15,610 | $19,536 |
| 2023 | 11 | 97 | $60,078 | $73,776 |
| 2022 | 25 | 178 | $50,418 | $63,998 |
| 2021 | 24 | 106 | $5,325 | $7,182 |
| 2020 | 20 | 80 | $4,184 | $6,742 |
| 2019 | 24 | 146 | $41,409 | $47,582 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Amgen | Repatha | $10,896 | 18 payments
|
| Medtronic | Ffrangio | $670 | 19 payments
|
| W. L. Gore & Associates | Gore Cardioform Septal Occluder | $175 | 2 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $74 | 4 payments
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $50 | 2 payments
|
See all 45 published payments
| Medtronic | Meals · 2025-12-18 | Ffrangio | $30 |
| Amgen | Meals · 2025-12-17 | Repatha | $7 |
| Medtronic | Meals · 2025-12-12 | Ffrangio | $9 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-12-10 | Camzyos | $20 |
| Medtronic | Meals · 2025-11-13 | Ffrangio | $34 |
| Shockwave Medical | Meals · 2025-11-12 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $24 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-11-06 | Camzyos | $20 |
| Medtronic | Meals · 2025-11-05 | Ffrangio | $40 |
| Medtronic | Meals · 2025-10-23 | Ffrangio | $35 |
| Medtronic | Meals · 2025-09-24 | Ffrangio | $33 |
| Amgen | Travel · 2025-09-22 | Repatha | $10 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-09-11 | Eliquis | $15 |
| Amgen | Paid to speak or teach · 2025-09-10 | Repatha | $2,800 |
| Medtronic | Meals · 2025-09-04 | Ffrangio | $33 |
| Amgen | Meals · 2025-09-03 | Repatha | $98 |
| Amgen | Meals · 2025-08-28 | Repatha | $24 |
| Medtronic | Meals · 2025-07-24 | Symplicity G3 | $35 |
| Amgen | Meals · 2025-07-15 | Repatha | $24 |
| Medtronic | Meals · 2025-07-09 | Ffrangio | $32 |
| Amgen | Meals · 2025-06-25 | Repatha | $7 |
| Medtronic | Meals · 2025-06-19 | Symplicity G3 | $33 |
| Medtronic | Meals · 2025-06-11 | Ffrangio | $30 |
| E.R. Squibb & Sons L.L.C. | Meals · 2025-06-06 | Eliquis | $18 |
| Medtronic | Meals · 2025-06-04 | Corevalve Evolut R | $137 |
| Medtronic | Meals · 2025-05-30 | Ffrangio | $5 |
| Amgen | Travel · 2025-05-23 | Repatha | $18 |
| Medtronic | Meals · 2025-05-22 | Symplicity G3 | $33 |
| Amgen | Meals · 2025-05-21 | Repatha | $7 |
| Amgen | Meals · 2025-05-21 | Repatha | $26 |
| Amgen | Paid to speak or teach · 2025-05-08 | Repatha | $2,800 |
| Amgen | Meals · 2025-05-02 | Repatha | $30 |
| Amgen | Paid to speak or teach · 2025-04-29 | Repatha | $2,800 |
| Amgen | Paid to speak or teach · 2025-04-29 | Repatha | $467 |
| Amgen | Travel · 2025-04-24 | Repatha | $924 |
| Amgen | Meals · 2025-04-23 | Repatha | $125 |
| Medtronic | Meals · 2025-04-16 | Ffrangio | $24 |
| Amgen | Meals · 2025-04-02 | Repatha | $29 |
| Medtronic | Meals · 2025-03-19 | Symplicity G3 | $27 |
| Amgen | Paid to speak or teach · 2025-03-14 | Repatha | $701 |
| Medtronic | Meals · 2025-03-13 | Ffrangio | $33 |
| W. L. Gore & Associates | Meals · 2025-02-25 | Gore Cardioform Septal Occluder | $34 |
| W. L. Gore & Associates | Meals · 2025-02-24 | Gore Cardioform Septal Occluder | $141 |
| Medtronic | Meals · 2025-02-05 | Ffrangio | $32 |
| Medtronic | Meals · 2025-01-23 | Symplicity G3 | $35 |
| Shockwave Medical | Meals · 2025-01-08 | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $26 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $19,536
| Merck Sharp & Dohme | Verquvo | $15,999 | 14 payments
|
| Amgen | Repatha | $2,955 | 4 payments
|
| Medtronic | Ffrangio | $382 | 14 payments
|
| CVRx | Barostim Neo System | $109 | 1 payment
|
| Inari Medical | Flowtriever Catheter, S | $52 | 2 payments
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $24 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $16 | 1 payment
|
2023: $73,776
| Merck Sharp & Dohme | Verquvo | $55,425 | 46 payments
|
| Lexicon Pharmaceuticals | Inpefa | $9,174 | 12 payments
|
| Amgen | Repatha | $8,181 | 9 payments
|
| Medtronic | Telescope | $671 | 23 payments
|
| Kestra Medical Technology Services | Assure Wcd | $167 | 1 payment
|
| Inari Medical | Flowtriever Catheter, S | $46 | 1 payment
|
| ShockWave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $28 | 1 payment
|
| Abbott Laboratories | Mitraclip | $27 | 1 payment
|
| Abiomed | Impella | $20 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $18 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $17 | 1 payment
|
2022: $63,998
| Merck Sharp & Dohme | Verquvo | $56,875 | 60 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $3,020 | 10 payments
|
| Sanofi-Aventis U.S. | Multaq | $1,903 | 9 payments
|
| Medtronic | Dxterity | $597 | 25 payments
|
| Abiomed | Impella | $210 | 6 payments
|
| Novo Nordisk | Ozempic | $191 | 6 payments
|
| Janssen Pharmaceuticals | Xarelto | $140 | 9 payments
|
| Shockwave Medical | Shockwave Ivl System With the Shockwave C2 Coronary Ivl Catheter | $140 | 8 payments
|
| Inari Medical | Flowtriever Catheter, S | $133 | 2 payments
|
| Boston Scientific | Synergy | $117 | 7 payments
|
| Actelion Pharmaceuticals US | Opsumit | $101 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $100 | 5 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $70 | 4 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $62 | 4 payments
|
| Pfizer | Vyndaqel | $48 | 2 payments
|
| Kiniksa Pharmaceuticals | Arcalyst | $44 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $42 | 3 payments
|
| Abbott Laboratories | Mitraclip | $42 | 2 payments
|
| Amgen | Repatha | $39 | 2 payments
|
| Amarin Pharma | Vascepa | $31 | 2 payments
|
| Janssen Scientific Affairs | Xarelto | $29 | 2 payments
|
| United Therapeutics | Tyvaso | $23 | 1 payment
|
| Philips Electronics North America | (9267) Angiosculpt Cv Rx | $17 | 1 payment
|
| Arbor Pharmaceuticals | Edarbi | $17 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $5 | 1 payment
|
2021: $7,182
| Amgen | Repatha | $3,028 | 8 payments
|
| Pfizer | Eliquis | $2,605 | 11 payments
|
| Medtronic | Telescope | $182 | 7 payments
|
| Bayer HealthCare Pharmaceuticals | Verquvo | $144 | 4 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $140 | 10 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $137 | 9 payments
|
| Janssen Pharmaceuticals | Xarelto | $102 | 6 payments
|
| Actelion Pharmaceuticals US | Opsumit | $100 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $92 | 6 payments
|
| Boston Scientific | Synergy | $87 | 4 payments
|
| Abiomed | Impella | $77 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $72 | 5 payments
|
| Esperion Therapeutics | Nexletol | $70 | 5 payments
|
| Novo Nordisk | Ozempic | $67 | 4 payments
|
| Merck Sharp & Dohme | Verquvo | $62 | 3 payments
|
| Kiniksa Pharmaceuticals | None | $41 | 2 payments
|
| Amarin Pharma | Vascepa | $29 | 2 payments
|
| Sanofi-Aventis U.S. | Multaq | $27 | 2 payments
|
| LivaNova USA | Lifesparc System | $27 | 1 payment
|
| Regeneron Healthcare Solutions | Evkeeza | $22 | 1 payment
|
| Arbor Pharmaceuticals | Edarbi | $20 | 1 payment
|
| AngioDynamics | Alphavac | $20 | 2 payments
|
| United Therapeutics | Orenitram | $18 | 1 payment
|
| CathWorks | Ffrangio | $14 | 1 payment
|
2020: $6,742
| AstraZeneca Pharmaceuticals LP | Farxiga | $3,318 | 7 payments
|
| Medtronic Vascular | Corevalve Evolut | $1,447 | 4 payments
|
| Amgen | Repatha | $1,061 | 12 payments
|
| Janssen Pharmaceuticals | Xarelto | $159 | 11 payments
|
| Boston Scientific | Synergy | $138 | 5 payments
|
| Amarin Pharma | Vascepa | $117 | 13 payments
|
| Sanofi-Aventis U.S. | Multaq | $108 | 5 payments
|
| Inari Medical | Flowtriever | $93 | 1 payment
|
| Abiomed | Impella | $50 | 2 payments
|
| Novartis Pharmaceuticals | Entresto | $49 | 2 payments
|
| Pfizer | Eliquis | $34 | 2 payments
|
| Chiesi USA | Kengreal 50mg/10ml L | $27 | 2 payments
|
| United Therapeutics | Orenitram | $22 | 1 payment
|
| Actelion Pharmaceuticals US | Opsumit | $22 | 1 payment
|
| Novo Nordisk | Ozempic | $21 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $18 | 1 payment
|
| Esperion Therapeutics | Nexletol | $18 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $15 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Adempas | $12 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $12 | 1 payment
|
2019: $47,582
| Novartis Pharmaceuticals | Entresto | $13,604 | 16 payments
|
| Amgen | Repatha | $13,419 | 25 payments
|
| Pfizer | Eliquis | $10,072 | 22 payments
|
| Abbott Laboratories | Amplatzer Cardiac Plug | $5,796 | 10 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $2,840 | 7 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $589 | 9 payments
|
| Boston Scientific | General Structural Heart | $256 | 8 payments
|
| Philips Electronics North America | Igt Devices Und | $189 | 3 payments
|
| Sanofi-Aventis U.S. | Multaq | $157 | 8 payments
|
| Janssen Pharmaceuticals | Xarelto | $108 | 11 payments
|
| Medtronic Vascular | Corevalve Evolut | $79 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $77 | 5 payments
|
| Portola Pharmaceuticals | Andexxa | $64 | 1 payment
|
| Actelion Pharmaceuticals US | Opsumit | $49 | 2 payments
|
| Amarin Pharma | Vascepa | $48 | 3 payments
|
| Regeneron Healthcare Solutions | Praluent | $43 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $40 | 2 payments
|
| Bardy Diagnostics | Carnation Ambulatory Monitor | $34 | 1 payment
|
| Edwards Lifesciences | Edwards Sapien 3 Transcatheter Heart Valve | $31 | 2 payments
|
| Biotronik | None | $19 | 1 payment
|
| Gilead Sciences | None | $19 | 1 payment
|
| United Therapeutics | Orenitram | $17 | 1 payment
|
| HeartFlow | None | $16 | 1 payment
|
| Kowa Pharmaceuticals America | Livalo | $14 | 1 payment
|
Research money
Money a company paid to run a study. Where it went to their institution, the clinician is named as an investigator and did not receive it; the amount covers the whole study, often across many sites.
| Akcea Therapeutics, Inc. · Isis 678354-Cs2 · 2019 | Their institution | $66,951 |
| Novartis Pharmaceuticals Corporation · Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor Arni Versus Ace Inhibitor Trial To Determine Impact on Serious Events After Myocardial Infarction Paradise Mi · 2019 | Their institution | $15,550 |
| Novartis Pharmaceuticals Corporation · Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor Arni Versus Ace Inhibitor Trial To Determine Impact on Serious Events After Myocardial Infarction Paradise Mi · 2020 | Their institution | $15,081 |
| Akcea Therapeutics, Inc. · A Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Phase 2 Study of Isis 678354 Administered Subcutaneously To Patients With Hypertriglyceridemia and Established Cardiovascular Disease (Cvd) Or at A High Risk for Cvd · 2020 | Their institution | $13,102 |
| Novartis Pharmaceuticals Corporation · A Randomized Double Blind Placebo Controlled Event Driven Trial of Quarterly Subcutaneous Canakinumab in the Prevention of Recurrent Cardiovascular Events Among Stable Post Myocardial Infarction Patients With Elevated Hscrp · 2019 | Their institution | $4,763 |
| Novartis Pharmaceuticals Corporation · Prospective Comparison of Angiotensin Receptor Neprilysin Inhibitor Arni Versus Ace Inhibitor Trial To Determine Impact on Serious Events After Myocardial Infarction Paradise Mi · 2021 | Their institution | $1,802 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 96.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1215038930
- Licence
- CA G42165California G42165: Current · expires 2028-06-30
- Trained
- Rutgers New Jersey Medical School, 1979 · 47 years ago
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RI0011X (207RI0011X)
- Mailing address
- 3400 Data Dr, Rancho Cordova, CA, 95670
- NPI first listed
- 2006-09-26
- NPI last updated
- 2024-03-15
- NPI record certified
- 2024-03-15
This is when the NPI record was last certified, not a medical board exam.